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ABSTRACT 
PSYCHONEUROIMMUNOLOGY AND HEALING TOUCH IN HIV DISEASE 
By Jo Lynne Wheeler Robins, Ph. D . ,  RN 
The purpose of this study was to ascertain the effects of Healing Touch (HT) on 
well-being and neuroendocrine function in individuals living with HIV disease. A total of 
27 males completed the 4-week HT intervention. Each weekly HT session lasted 30  
minutes and consisted of  only the chakra connection . Because of  the small sample size and 
the impact of gender on neuroendocrine and immune function, women were not included 
in this study. Dependent variables included well-being as measured by three well-being and 
two psychological distress instruments, serum serotonin, salivary DHEA and cortisol, and 
a variety of enumerative and functional measures of immune function A pretest-posttest 
design experimental design including a wait-list control group was used. Multivariate 
analysis of covariance was used to test the research hypotheses followed by univariate 
analysis of variance to detect the contribution of individual variables to the overall 
multivariate models. It was hypothesized that HT would increase participant well-being, 
serum serotonin and salivary DHEA; decrease salivary cortisol; and improve immune 
function in individuals living with HIV disease. All of the research hypotheses were 
rejected. Discussion of the results as well as directions for future research are presented. 
VI 
Chapter 1 
Introduction 
Psychoneuroimmunology (PNI) is the study of the complex relationships among 
behavior and the neuroendocrine and immune systems. Bi-directional communication 
pathways exist between the neuroendocrine and immune systems. In humans, it is thought 
that certain behaviors affect these interactions and ultimately health outcomes (Ader, 
1 992; Ader, Cohen, & Felton, 1 995; Black, 1 995). PNI is an outgrowth of research done 
over 40 years ago exploring the effects of stress on the immune system. In the late 1 970's 
the discovery of endorphins and their role in endogenous pain control was pivotal in the 
emergence of psychoneuroimmunology as a significant field of study (Poole, 1 993 ) .  
Evidence suggests that endorphins as well as other chemicals produced by the 
neuroendocrine and immune systems are part of an intricate mind-body network operating 
to preserve health and mediate disease processes (Black, 1 994; Dossey, Keegan, Guzzetta, 
& Kolkmeier, 1 995) 
Peptides in the form of neurotransmitters, for example, mediate intercellular 
communication throughout the brain and body. These peptides and their receptors are the 
"biochemical correlates of emotions" (Pert, 1 993, p. 1 78) According to Pert, the 
discovery of mood-altering chemicals that interact with the immune system implies that it 
should be possible for individuals to achieve a mental state that positively affects the 
immune system. 
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A variety of therapies, including energy therapies, such as healing touch, may have 
the potential to induce a mental state conducive to enhanced immune function. For 
thousands of years, in eastern as well as western thought, the human body has been 
conceptualized as an energy field. It is conceived as a manifestation of universal energy, 
the basic constituent and source of all life .  The human energy field (HEF) is a "luminous 
body that surrounds and interpenetrates the physical body, emits its own characteristic 
radiation and is usually called the aura" (Brennan, 1 987, pAl ) . The HEF or aura is 
comprised of seven layers, with each layer having its own particular appearance and 
function . Each layer contains chakras, which are essentially energy vortexes that connect 
the HEF to the environmental and universal energy fields. Each chakra is thought to 
correspond to a specific endocrine gland and particular area of the body. One of the 
primary functions of the chakras is to vitalize and energize the HEF and physical body. 
Energy-based therapies have been developed that allow assessment and manipulation of 
the HEF to enhance health and well-being. Healing touch (HT) is an energy-based 
therapeutic technique theorized to influence the chakras and human energy field ultimately 
to impact physical, psychological, and spiritual health and well-being (Dossey et ai , 1 995) .  
HT is theorized to elicit effects through an energy exchange between practitioner 
and recipient . However, direct measurement of this energy exchange is not currently 
possible. Research to date on energy therapies has focused on various indirect measures of 
psychological and physiological effects thought to be involved in mind-body interactions. 
Psychoneuroimmunology provides a well-studied framework for investigating and 
understanding the intricacies and significance of the relationship between the mind and the 
body. In this research, the PNI conceptual framework was used as the foundation for a 
J 
clinical trial examining the effects of HT on the psychological parameter of well-being; the 
neuroendocrine parameters of bioavailable serum serotonin, salivary 
dehydroepiandrosterone (OHEA) and cortisol; and the immunological parameters of 
lymphocyte proliferation to phytohemagglutinin (PH A), natural killer (NK) cell activity, 
C04+ and C08+IC057+ lymphocyte levels, and selected type 1 and type 2 cytokine levels 
in individuals infected with the human immunodeficiency virus (HI V). These parameters 
were chosen because of their interrelationships within the PNI framework and the 
potential of the interrelationships to affect positively neuroendocrine and immune function 
in individuals living with HIV disease . HT was chosen because of its potential to enhance 
immune function through its ability to enhance well-being. This study will add to a 
growing body of scientific investigations of PNI and energy-based therapies. 
Purpose 
The purpose of this study was to ascertain the effects of HT on selected PNI 
parameters in HIV -infected participants It was hypothesized that HT would increase 
participant well-being, which subsequently would increase both serum serotonin and 
salivary OHEA, decrease salivary cortisol, and ultimately enhance immune function. 
Specific research hypotheses were that HT would (I) enhance well-being, (2) increase 
levels of serum serotonin and OHEA, (3 ) decrease levels of salivary cortisol, and (4) 
enhance immune function in persons with HIV disease. Ultimately, HT may be beneficial 
as part of a comprehensive, integrative program combining allopathic and complementary 
therapies to improve the quality of life and survival of persons living with HIV disease. 
However, decision-making regarding clinical applicability of energy therapies requires 
further scientific evaluation. 
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Conceptual Framework 
The conceptual framework for this study is presented schematically in Figure 1 .  
Human beings are conceptualized as energetic beings comprised of contiguous, continually 
interacting human and environmental energy fields. Energy-based therapies such as HT 
allow practitioners to assess and correct imbalances in the energy field to promote health 
and well-being. Because PNI encompasses a holistic view of mind-body interactions, it 
provides a framework for investigating therapies such as HT that potentially can impact 
the interactions among psychological factors such as well-being and neuroendocrine and 
immune function 
Healing Touch 
Brennan ( 1 987) provided a comprehensive history of energetic healing in Hands of 
Light A Guide to Healing through the Human Energy Field .  Throughout history, in both 
the east and west, are descriptions of a universal energy pervading all living things. In 
traditional Chinese medicine, it is known as chi. In Ayurvedic medicine, it is called prana. 
This energy was first described in the west around 500 BC by the Pythagoreans. This vital 
energy manifests itself in human beings as a human energy field (HEF). Since the 1 2 1h 
century, western science, through various techniques including photographic and 
electromagnetic procedures, has accumulated evidence to support the presence of a HEF. 
Based on observations over the centuries, a theoretical model has been developed 
that describes the energy field as being composed of seven layers. The seven layers are 
connected to the physical body, to each other, and to universal energy by chakras or 
energy vortexes. Disturbances or imbalances in the HEF can be assessed and altered 
intentionally through the chakras. As mentioned, each chakra is believed to correspond to 
a specific endocrine gland and particular area of the body. A diagram of the seven major 
chakras and their theoriied corresponding endocrine glands and body regions is provided 
in Appendix A. Because the chakras are believed to vitalize the body, they are directly 
related to health and illness. According to Moore ( 1 997), "the basic premise of most 
energy medicine models is that dysfunctions occurring with the chakras translate down 
into the physiological level" (p .  47) 
HT is an energy-based therapy developed in the 1 980's  by Janet Mentgen, based 
on earlier work by Kunz and Krieger (Brennan, 1 987) .  The underlying premise of HT is 
consistent with ancient descriptions of the body as a complex energy system whose 
physiological functions are influenced by the flow of that energy. Through the use of HT, 
it is postulated that a recipient's energy flow can be assessed and balanced. The particular 
HT technique used in this trial was the chakra connection, which is used to balance and 
connect the major energy centers or chakras. The purpose of the chakra connection is to 
restore balance in the human energy field to promote psychological and physiological 
health. Eisenberg (1993 ), a western-trained physician and expert in traditional Chinese 
medicine, stated that "energy medicine" is in no way inferior to synthetic drugs and other 
biomedical therapies, it simply uses a different approach to health and il lness However, 
well-designed trials are needed to assess the effects of energy-based therapies. 
Well-being 
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For the purpose of this study well-being was a measure of the potential effects of 
HT as well as the primary link between HT and PNI .  Well-being has been defined as "the 
state of being generally healthy, happy, or prosperous" (Riverside Webster ' s  II Dictionary, 
1 996, p .  769) . According to Bradburn ( 1 969), well-being is conceptualized as having an 
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affective-emotional component as well as a cognitive-judgmental component . Basically, an 
individual experiences positive well-being when positively perceived emotions outweigh 
negatively perceived emotions, and vice versa. It is not the absolute amount of positive or 
negative emotion that determines the affective-emotional aspect of well-being, but the 
balance between the two . The cognitive-judgmental component reflects the individual ' s  
satisfaction with life. Thus, subjective well-being is the individual ' s  perception of  the 
balance of positive and negative emotions as well as satisfaction with his or her goals in 
life and the perceived potential to achieve these goals 
Consistent with Bradburn's conception of well-being, Dossey and colleagues 
( 1 995 ) defined well-being as a process of increasing awareness of reaching human 
potentials According to the Rogerian energetic framework, well-being can be 
conceptualized in terms of human field image (HFI). Generally, HFI is an individual 
perception of the infinite wholeness of the human field (Johnston, 1 994) Johnston defined 
HFI as "one manifestation of the human and environmental patterning process, which may 
be expressed as a perception of one's potential and an awareness of one ' s  integrality" (p .  
8 ) .  Perceived potential encompasses concepts related to the perception of the presence or 
absence of boundaries, while integrality represents manifestations of the perceived human­
environmental mutual process. Thus, well-being can be conceptualized as an individual 
perception comprised of physical, psychological, and energetic dimensions encompassing 
overall health, positive and negative emotions, as well as the recognized potential for 
achieving and maintaining well ness and balance in life. 
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Immune Function 
The functioning Of the immune system is orchestrated by a variety of cells and 
cellular products .  Immune cells are collectively identified as leukocytes or white blood 
cells (WBC' s) .  WBC ' s  are divided into three main categories: lymphocytes, monocytes, 
and granulocytes. Functional differences exist among these broad categories with further 
distinctions delineated among lymphocyte subpopulations. Lymphocytes are divided into B 
cells, T -helper cells, T -suppressor cells, and NK cells .  B cells protect against bacterial 
infections and produce antibodies. T -helper cells stimulate immunological activities, and 
T -suppressor cells down-regulate immune responses. NK cells are non-specific cytotoxic 
or cell-kil ling cells .  Unlike other cytotoxic lymphocytes, they do not require prior 
sensitization to induce a cytotoxic response. They provide antiviral and antitumor 
protection. Because there are so many different cells performing so many different 
processes, immune function can be assessed using a variety of approaches. Enumerative 
measures assess the number and/or percentage of particular cells . Functional assays assess 
processes such as lymphocyte proliferative response to antigens, specific cytotoxic 
activities, and the ability to generate humoral regulatory substances such as antibodies and 
cytokines (Weisse, 1 992) .  
HIV Disease 
According to Folkman ( 1 993 ), the psychosocial effects of HI V disease cannot be 
understood without some basic understanding of HIV disease. HIV is transmitted through 
interpersonal sexual contact with an infected individual, exposure to contaminated blood 
or blood products, and perinatally from an infected mother to her infant . The physical 
course of HIV varies widely. Within several weeks of infection, individuals can develop a 
self-limited acute illness that is similar to mononucleosis, with fever, sore throat, malaise, 
skin rash, headache, and lymphadenopathy. Following resolution of this illness, there is 
usually an extended incubation or "latent" period, which varies in length from 1 to 1 0  
years. During this latent phase, individuals are relatively healthy with periodic symptoms 
such as lymphadenopathy, fatigue, low-grade fevers, and other non-specific symptoms. 
Some individuals have no physical symptoms or laboratory abnormalities during this time. 
The next phase is marked by minor infections such as oral candidiasis, herpes 
zoster, and recurrent herpes simplex outbreaks. Other non-specific symptoms that can 
occur during this time include fevers, night sweats, weight loss, diarrhea, and skin rashes. 
As the disease progresses and cellular immunity becomes more impaired, opportunistic 
infections, tumors, neurological disorders, and more severe weight loss (> 1 0% of ideal 
body weight) develop. The aforementioned non-specific symptoms usually continue. The 
diagnosis of AIDS is established with the occurrence of any of the AIDS-indicator 
conditions defined by the Centers for Disease Control and Prevention (CDCP) such as 
pneumocystis pneumonia, wasting syndrome, and encephalopathy. HIV medication 
regimens are focused on inhibiting viral reproduction, maximizing immune function, and 
preventing concurrent infections Because of the extended asymptomatic phase and the 
stabilizing effects of medications, HIV is now considered a chronic disease (Folkman, 
1 993 ) .  
PNI 
PNI is the study of the complex interactions among behavior and the 
neuroendocrine and immune systems. It is considered a holistic framework because it 
encompasses these interactions, which were previously conceptualized as separate and 
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isolated entit ies. The field of PNI grew from the realization that the immune system does 
not function autonomously. Currently the immune system is perceived as a large sensory 
organ providing indirect feedback to the central nervous system (CNS) through messenger 
chemicals such as cytokines. The CNS is physically and systemically connected to the 
immune system by the autonomic nervous system and neuroendocrine outflow from the 
pituitary gland. Sympathetic neurons innervate immune organs including the thymus, bone 
marrow, spleen, and lymphatic system. These nerve fibers communicate directly with 
immune cells such as lymphocytes. Lymphocytes express soluble mediators for CNS and 
neuroendocrine substances, such as hormones and neurotransmitters, and have specific 
receptors for such mediators on cell membrane surfaces. The immune system is also 
influenced by neuroendocrine outflow from the pituitary Following the release of 
stimulating substances from the pituitary, the adrenal cortex produces two steroid 
hormones that affect immune function : cortisol and DHEA (Ader, Cohen, & Felten, 
1 995 ) 
Cortisol is the major glucocorticoid produced by humans and potentially the most 
important steroid hormone influencing immune function within the context of PNI .  
According to Reichlin ( 1 993 ), cortisol, when produced in excess, has the potential to 
interfere with virtually al l  components of the immune response. Cortisol reduces 
lymphocyte numbers as well as cellular function (Hillhouse, Kiecolt-Glaser & Glaser, 
1 991 ; O 'Leary, 1 990; Stein & Miller, 1 993 ) .  Its immunosuppressive effects are often 
related to regulatory interference with cytokines (Clerici, Bevilacqua, Vago, Villa, & 
Norbiato, 1 994) 
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DHEA is produced in the adrenal cortex and is the most abundant steroid hormone 
in the body. Research exploring the physiological role of DHEA confirms its major 
regulatory function in the immune system (Regelson, Loria, & Kalimi, 1 994) .  For 
example, Khorram, Vu, and Yen ( 1 997) found that immune function improved 
significantly following oral supplementation of DHEA in aged men. Increased numbers of 
monocytes, NK cells, and B-lymphocytes, as well as an increase in lymphocyte 
proliferation evidenced enhanced immune function. 
Psychological modulation of immune function has been investigated in two 
primary areas : classical conditioning and the impact of stress. Ader and Cohen ( 1 975,  
1 993 ) paired a saccharin solution with cyclophosphamide (a chemotherapy agent) and 
demonstrated a conditioning effect on the immune system in the form of significant 
immunosuppression when the saccharin solution was given without the 
immunosuppressive drug. This discovery was a pivotal finding in the development of the 
field of PNI .  Solvason, Ghanta, and Hiramoto ( 1 988)  also demonstrated conditioned 
immune enhancement. 
Stressors activate the sympathetic nervous system as well as the hypothalamic­
pituitary-adrenal axis, thereby potentially impacting immunity. Although Selye ( 1 956) 
originally proposed a model of nonspecific responses to various stressors, it is now 
accepted that different types and patterns of stressors can produce different patterns of 
autonomic responses (Mason, 1 97 1 )  Additionally, individual factors such as personality, 
coping styles, and affective states can modulate physiological responses (Friedman & 
Booth-Kewley, 1 987; Chesney & Rosenman, 1 983 ; Herbert & Cohen, 1 993 ). 
There is increasing evidence that immune processes occur within a neuroendocrine 
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environment that is "sensitive to the influence of the individual ' s  perception of and 
response to events in the external world" (Ader, Cohen, & Felton, 1995, p . 1 00). PNI 
provides a framework for conceptualizing and investigating the means by which 
psychosocial factors and affective states can influence the development and progression of 
immunological diseases. 
PNI in HIV Disease 
To date, much of the research done in the field of PNI has focused on individuals 
with impaired immune function, such as those individuals living with HIV disease, because 
even subtle changes in the neuroendocrine and immune systems of these individuals are 
potentially helpful in maintaining adequate immune function and health. Cellular immune 
reactions are under the regulation of two categories of lymphocytes, T -helper (CD4+) and 
T -suppressor (CD8+) cells . The relative numbers and function of these lymphocytes 
influence the strength and persistence of immune responses. HIV primarily infects the 
CD4+ helper/inducer lymphocyte, a key cell type in regulation of both cell-mediated and 
humoral immune responses. Ultimately, HIV destroys CD4+ cells; measurable reductions 
in CD4+ lymphocyte counts occur when cell destruction exceeds cell replication. This 
decline in CD4+ lymphocytes correlates with HIV disease progression. With disease 
progression, in addition to T -lymphocyte functional impairment, NK cell function is also 
impaired (Brenner, Dascal, Margolese, & Wainberg, 1 989; Clerici et a1 . ,  1 989) 
NK cells are part of the host's natural immunity to HIV -associated disorders and 
opportunistic infections. In vivo, NK cells play a vital role in fighting infections by 
producing cytokines, such as tumor necrosis factor (TNF)-alpha and interferon (lFN)­
gamma, even before T-cell activation occurs. Generally, there is no significant enumerative 
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change i n  NK cells i n  HIV disease. However, NK cell function may be of major prognostic 
significance in AIDS pathogenesis. Normally, NK cells spontaneously lyse virally infected 
and cancerous cells. However, NK cells become functionally defective as HIV disease 
progresses and the cause of this dysfunction remains unknown (Brenner, Dascal, 
Margolese, & Wainberg, 1 989; Chehimi et aI , 1 992; Sirianni, Tagliaferri, & Aiuti, 1 990) .  
According to  Clerici and Shearer ( 1 993 , 1 994), an immune system imbalance 
occurs in HIV disease that further weakens the immune system and accelerates the 
progression to AIDS .  They proposed a shift from type 1 to type 2 cytokine regulation as a 
critical step in the progression of HIV infection. Cytokines may be an immunologic marker 
of HIV disease progression Increased levels of soluble cytokine receptors in HIV -infected 
individuals are associated with a chronic state of cellular activation that is an important 
part of the pathogenesis of HIV disease. According to Poli and Fauci ( 1 996), this ongoing 
immune activation likely contributes to a state of persistent HIV replication, underlying a 
vicious cycle of activation and virus replication that fosters the progression of HIV 
disease. 
Cytokines are proteins that function through intercellular receptor binding. They 
regulate immune system functioning including cellular and humoral immune responses. 
Cytokines are known to be behaviorally, endocrinologically, immunologically, and 
electrophysiologically active (Ader, Cohen, & Felton, 1 995) .  The cellular and humoral 
arms of the immune system tend to counteract each other by cytokine regulation. Evidence 
suggests cytokine response patterns are involved in immunomodulation (Mosmann & Sad, 
1 996) .  Generally, a type 1 cytokine pattern (including interleukin-l [IL-l], IL-2, IL- 1 2, 
IFN-gamma, and TNF-alpha) enhances cellular immunity, while a type 2 pattern (including 
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IL-4, IL-S, IL-6, IL-9, IL- I 0, and IL- 1 3 ) diminishes cellular immunity and enhances 
humoral immunity. Type '1 cytokines stimulate effector responses to viral infection and 
other intracellular pathogens through activation of NK cells and cytotoxic lymphocytes. 
Type 2 cytokines support effector responses to bacterial and parasitic infections and 
mediate allergic responses by promoting antibody production. Cross-regulation exists 
between type I and type 2 cytokine responses. For example, IFN-gamma and IL- 1 2  
functionally down-regulate type 2 responses and IL-4 and IL- I 0 functionally down­
regulate type I responses. Conversely, inhibition of IFN-gamma and IL- 1 2  will augment 
type 2 responses and inhibition of IL-4 and IL- I 0 will enhance type I responses (Shearer 
& Clerici, 1 992; Clerici & Shearer, 1 993 ; Levy, 1 993 ; Kuby, 1 994) .  While these 
mechanisms are generally exhibited, the exact role of cytokines remains a complex issue. 
Depending on the cytokine milieu and/or functional status of an infected cell, IFN-gamma, 
IL-4, and IL-l 0 can act as positive or negative modulators (Poli & Fauci, 1 996) . Shearer 
and Clerici ( 1 996) acknowledged that their theory does not take into account the 
"interaction of immunoregulatory cytokines produced by the many different cell types 
operating in a dynamic and open system" (p. 230) 
The progressive dysfunction of the immune system in HIV disease ultimately 
results in increased susceptibility to opportunistic infections and the clinical syndrome of 
AIDS .  However, the clinical course of HI V is highly variable with or without treatment . 
The variability in the clinical and biological course of HIV may be due solely to properties 
of the virus itself, although it is most likely that environmental and/or host cofactors also 
influence disease progression (Kemeny, 1 994) .  Although the relationships among behavior 
and mood, immune function, and HIV disease progression are not yet clear, there is 
reason to believe these relationships exist (Schneiderman, 1 994) .  
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In a review of stressful events, psychological responses, and progression of HIV 
disease, Kemeny ( 1 994) cited multiple physiological and psychological cofactors for HIV 
disease progression, including substance abuse, malnutrition, sexually transmitted diseases, 
the presence of other viral infections, and negative affective states such as dysphoria, 
bereavement, fatalistic thinking, and hopelessness. Currently, there is little empirical 
support for the relationship between psychological well-being and immune function. 
However, stress and coping effectiveness are considered cofactors for HIV disease 
progression and there is significant empirical support for a relationship between stress and 
psychological distress, or the individual ' s  reaction to stress, and HIV disease progression 
(McCain & Zeller, 1 996) Similar mechanisms may be responsible for the relationship 
between dysphoric or negative affective states and immunosuppression (Herbert & Cohen, 
1 993 ) Additionally, the relationship between stress and immune function is mediated, in 
part, by an individual's  perception of potentially stressful events. Similarly, an individual ' s  
mood could potentially mediate immune function. Whereas a negative affective state may 
diminish immune function, a positive affective state may enhance immune function. In a 
comprehensive review of studies involving PNI and HIV disease, McCain and Zeller 
( 1 996) concluded that because of the paucity of studies of well-being as well as design and 
validity problems, there is currently little empirical support for relationships between well ­
being and immunity. They proposed two research priorities (a) investigating the 
effectiveness of nursing interventions in HIV disease, and (b) identification of 
biobehavioral factors and testing interventions that foster immunocompetence. This 
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clinical trial contributes t o  the developing knowledge base o f  the effectiveness of the 
biobehavioral intervention of HT in fostering immunocompetence in individuals living with 
HIV disease . It was proposed that HT may enhance well-being because of its potential to 
elicit the relaxation response and decrease anxiety and physical discomfort. It is 
conceivable that interventions, such as HT, that enhance well-being and possibly neurally 
mediated immune function, may enhance quality of life as well as retard HIV disease 
progression. This trial was needed to investigate the host cofactor of well-being, a global 
indicator of an individual ' s  perception of their day-to-day life and long-term aspirations, 
and its possible effects on the neuroendocrine environment and immune function in 
individuals living with HIV disease 
In summary, PNI provides a holistic framework for examining interactions among 
psychological states and the neuroendocrine and immune systems. This framework is 
particularly applicable in immunologically mediated diseases such as HIV disease . PNI 
research in HIV disease has focused primarily on the impact of stress and negative 
affective states on disease progression, while the potential impact of positive affect 
remains largely unexplored. HT and other energy therapies are theorized to focus on 
healing at the quantum and electromagnetic levels in individuals. These therapies are also 
associated with the elicitation of the relaxation response. Generally, these therapies have 
the potential to enhance well-being in a variety of ways, although the exact mechanisms of 
action are not yet known. In this research, PNI serves as an organizing paradigm for 
investigating the effects of HT on well-being in individuals living with HIV disease . It was 
specifically proposed that HT had the potential to improve well-being, thereby eliciting 
favorable changes in the neuroendocrine environment and ultimately enhancing immune 
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function Despite the complexity of  investigating immune function i n  the presence of 
somewhat unpredictable and often inadequately understood immune dysfunction, if even 
subtle effects of HT on neuroendocrine and immune function are detected, their impact 
may be clinically significant in individuals with impaired immune function. This trial sought 
to examine the effects of HT on well-being and ultimately immune function, but because it 
was not a longitudinal study, it provided only theoretical conclusions about health 
outcomes. 
Significance 
P NI provides a comprehensive conceptual framework for investigating the 
relationship between the mind and the body as well as interventions that may influence this 
relationship .  Research indicates that stress and its correlate, psychological distress, can 
alter immune function, thereby influencing disease susceptibility (McCain & Smith, 1 994) 
However, investigations into the clinical applicability of mind-body interventions for 
promoting health and treating disease are limited (Zeller, McCain, & Swanson, 1 996) . The 
research that does exist focuses on the impact of distress or negative affect, while the 
effects of positive affect or subjective well-being have been largely unexplored. It is 
theoretically sound to propose that if negative affect can impair immune function, then 
positive affect may enhance immune function. In individuals whose immune function is 
impaired, as is the case in individuals living with HIV disease, even subtle changes in 
immune function could affect health. This clinical trial provided valuable insights into the 
the effect of HT using a P NI paradigm. 
Figure 1. Conceptual Framework: Psychoneuroimmunology and Healing Touch in HIV Disease 
Chapter 2 
Review of Research 
The components of the research review are structured according to the purpose of 
this clinical trial, the investigation of the effects of HT on well-being , the neuroendocrine 
environment, and immune function in individuals living with HIV disease. The review is 
representative of the applicable research that exists in the areas of energy therapies, well­
being, the interactions among the neuroendocrine and immune systems, immune 
dysfunction in HIV disease, and the field of PNI in HIV disease . 
Healing Touch 
Only two studies evaluating the effects of HT were found in peer reviewed 
journals. In an anecdotal case study, HT was shown to facilitate healing of a cesarean 
wound infection (Wetzel, 1 993 ) .  HT was performed every other day for 1 2  days (from 
postoperative day 8 through 1 9), then on postoperative days 25 , 3 1 , and 47. Generally, 
the treatment consisted of magnetic unruffiing followed by the conscious direction of 
energy into the wound. This patient also received standard wound care, including oral 
antibiotics and wound irrigation and dressing changes three times a day while the open 
wound healed by second intention. Other patients who had wound infections during the 
same time period as the patient in the case study had taken 9 to 1 6  weeks to heal . 
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Wetzel reported the patient treated with HT had a similar wound but was fully healed i n  6 
weeks. However, the lack ·of research controls for this study obviated meaningful 
compansons. 
In the other study, HT was shown to decrease postoperative pain. Silva ( 1 996) 
assessed the effects of HT on postoperative pain, relaxation levels, and physiological 
functioning in a sample of 60 women who had abdominal hysterectomies. Participants 
were assigned randomly to one of three groups HT, back massage, or no treatment . Each 
group consisted of 20 participants. The treatment group received a 20-minute HT 
intervention while one control group received a 20-minute back massage and the other 
control group received standard postoperative care on the day of surgery and 24 and 48 
hours after surgery. A nursing assessment, including vital signs, and activity level as well 
as lung, gastrointestinal, urinary, and motor function, was performed before and after each 
session and on the third postoperative day. The amount of self-administered narcotic 
analgesia and the number of medications and treatments to stimulate bowel function were 
recorded daily. Data were analyzed using repeated measures analysis of variance and 
analysis of covariance. Participants who received HT experienced a higher level of 
recovery as evidenced by more rapidly improved lung and gastrointestinal function as well 
as higher activity levels when compared to the back massage and control groups. The HT 
group also experienced statistically significant reductions in systolic and diastolic blood 
pressure and pulse rates. Additionally, the HT group received significantly less narcotic 
analgesia and fewer bowel treatments compared to the other groups. 
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I n  a doctoral dissertation published i n  Dissertation Abstracts International, Slater 
( 1 996) investigated the effects of HT on chronic non-malignant abdominal pain in 23 
participants who had a history of abdominal surgery. Each participant received three 
different treatments on separate days HT administered by experienced practitioners, HT 
administered by inexperienced or "naive" practitioners, and an interview. The order of the 
treatments was randomly assigned . The treatments given by the experienced and 
inexperienced practitioners were identical, consisting of the HT techniques of magnetic 
unruffiing and wound sealing. The interview was used as a placebo control to assess 
whether HT elicited a greater response than did a nurse being and talking with a patient in 
pain. Pain perception was measured before and after treatments using the McGill-Melzack 
Pain Questionnaire (MMPQ). Additionally, qualitative data exploring the practitioners' 
and recipients' experiences were collected then analyzed using content analysis. There 
were no significant differences in pain perception as measured by the MMPQ following 
either of the HT sessions. Inexperienced practitioners experienced more physical 
discomfort during sessions than did the experienced providers. Interestingly, the recipients 
preferred the inexperienced practitioners because the recipients experienced more nausea, 
headaches, dizziness, and drowsiness with the experienced practitioners. However, 
participants subjectively reported greater pain relief and relaxation following treatments 
with experienced HT practitioners despite the increase in other symptomatology. The 
author proposed this may indicate that the MMPQ differentiates between dimensions of 
pain, but that individuals experiencing pain may evaluate their pain based on criteria other 
than pain sensations. In this investigation, HT did not decrease postoperative pain 
significantly. The effect of the therapeutic interview on pain levels was not mentioned in 
the abstract . The small sample size may have contributed to the lack of statistical 
significance. 
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Healing Touch International publishes an annual survey of HT research containing 
information on upcoming, ongoing, and completed research. The survey includes abstracts 
of the completed HT research. Several of these studies are applicable to this research and 
therefore are included in this review of the literature. Some of these studies were recently 
completed and publications are in process. However, the majority of them are not being 
published in professional journals. Although the studies provide some potentially valuable 
information about the experience and effects of HT, they generally lack adequate 
methodological rigor. 
DuBrey ( 1 998) explored perceived effectiveness of HT treatments in a 
convenience sample of 25 individuals visiting a rural wellness center. The participants 
were ambulatory patients visiting a community-based well ness center; however their health 
status was not mentioned in the abstract . Following a single HT session, individuals were 
asked to rate pain perception, stress perception, and emotional well-being on a 1 to 1 0  
scale, with 1 being the least change and 1 0  being the greatest . Participants were asked to 
document the lasting effectiveness of treatment at 1 to 3 days, 4 to 7 days, 1 to 2 weeks, 
and greater than 2 weeks. None of the participants experienced an increase in pain or 
stress or a decrease in well-being following treatment . A total of 92% (n=23)  experienced 
decreased stress following HT, 68% (n= 1 7) experienced decreased pain, and 88% (n=22) 
experienced an increase in well-being. The reduction in stress levels persisted for up to 3 
days in 3 6% of participants, up to 7 days in 20%, up to 2 weeks in 1 1  %, and greater than 
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2 weeks in 28% of participants. Pain reduction was sustained for up to 3 days in 33% of 
participants following heali ·ng touch, up to 7 days in 28%, up to 2 weeks in 1 1  %, and 
greater than 2 weeks in 28% of the participants .  Increased levels of emotional well-being 
persisted for up to 3 days in 1 2% of the participants, up to 7 days in 3 2%, up to 2 weeks 
in 1 6%, and greater than 2 weeks in 40% of participants following HT. The researcher 
concluded that 88% of individuals reported a significant increase in their feelings of 
emotional well-being and 40% of those individuals experienced increased well-being that 
persisted for more than 2 weeks. Caution is required when interpreting the findings of this 
study because there was no control group and all measures were highly subjective and 
vulnerable to reactivity. 
One investigator examined the effects of HT on depression. Leb ( 1 998) recruited 
30 individuals with moderate to severe depression, as measured by the Beck Depression 
Inventory, then randomized them into treatment and no treatment control groups. The 
treatment group received HT twice a week for 3 weeks. They received the same treatment 
each week, consisting of centering, chakra spread (to open the energy field), magnetic 
unruftling (to clear any debris or imbalance in the field), modified mind clearing (to 
balance neurochemicals), seventh chakra spread (to clear the individual/universal 
connection), and terminating the session. The participants who received HT were 
significantly less depressed at the end of the 3-week intervention as compared to the 
control group who received no HT treatment . Depression levels were assessed one month 
later and the treatment group continued to demonstrate lower levels of depression 
compared to baseline. Information about the equivalence of groups at baseline was not 
addressed. No alternate explanations were offered for the improvement in the treatment 
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group such as social support, medications, or psychotherapy. Additionally, these variables 
were not addressed as pote·ntial confounders. 
One qualitative investigator explored the subjective experience of the chakra 
connection, the HT technique proposed in this trial . Moreland ( 1 998), in a 
phenomenological inquiry, asked six women who were undergoing intravenous 
chemotherapy for breast cancer to describe the experience of receiving HT with as much 
detail as possible. Three primary themes were identified. The experience was perceived as 
(a) caring expressed as a partnership, a nurturing act, and as self-care; (b) creating altered 
consciousness of the passage of time, the surrounding environment, of thought, and of the 
presence of the practitioner; and (c) a holistic experience involving physical, 
mental/emotional, and spiritual dimensions. The author concluded that HT for this group 
of participants was a "holistic, caring, and variable experience which altered their 
perception of self, time, and their surrounding environment in a positive way. This helped 
them 'get through' the experience of the chemotherapy" (p .  1 1 ) This was a well-designed 
and conducted phenomenological inquiry providing insight into the experience of receiving 
HT, but because of its qualitative design the findings cannot be generalized to other 
practitioners and recipients. 
Wilkinson ( 1 998) is currently conducting a three-phase study focused on 
understanding the effects of energetic healing. Phase 1 of the research was a qualitative 
exploration into the experience of receiving HT and has been completed. Phases 2 and 3 
are in progress. Phase 2 is quantitative and involves laboratory analysis of salivary IgA 
concentrations before and after HI. Phase 3 will involve integrating Phases 1 and 2. In 
Phase 1 ,  the researcher interviewed 1 2  HT practitioners and 7 HT recipients about the 
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experience of HT. The inquiry involved details about the experience, whether or not HT 
promoted health and personal growth, and from the recipients' perspectives, which 
elements of HT were perceived to be the most effective. Following content analysis, five 
themes were identified : changes, relaxation, an awareness of process, practitioner 
deliberateness, and heightened holistic awareness. All recipients except one reported 
positive changes following HT. The perceptions of the recipient whose experiences were 
unfavorable were not described in the Healing Touch International report . Relaxation, 
physical touch, and energy exchange were the answers given most frequently when 
recipients were asked which elements of HT they found most beneficial Details about the 
practitioners' responses were not included in the research abstract . Once again, 
information about the experience of receiving HT is provided which may infuse meaning 
when interpreting the psychophysiological responses to HT. However, data generation and 
analysis procedures and issues related to rigor and t rustworthiness were not addressed in 
the abstract . 
Included in the HT survey was a brief report regarding data informally collected by 
Lorene spanning greater than 300 hours of work with HI V-seropositive clients in her 
capacity as a volunteer at the Holistic AIDS Response Program at the University of 
California at San Diego. Because the sample was comprised of HIV -seropositive 
individuals treated with the chakra connection, this research is included here as reported 
through personal communication with the researcher. During I -hour HT sessions, the 
researcher performed magnetic unruffiing, chakra connection, and a modified brain 
balance technique. C lients were typically dealing with symptoms related to pain or 
agitation or both. In clients experiencing pain, pre- and post-treatment evaluations of pain 
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were completed using a 1 - 1 0  scale, with 1 being "minimal pain" and 1 0  being "the worst 
pain ever ." Responses in the 8-9 range consistently dropped to 0 by the end of the HT 
session. To assess agitation, clients' verbal responses were assessed before and after HT. 
Subjective reports consistently demonstrated considerable agitation or anxiety pre­
treatment and feeling calm and relaxed post-treatment . Lorene stated that HT is part of 
routine HIV -related care at the holistic center because the outcomes are so positive (10 
Lorene, personal communication, November 1 3 , 1 998) .  These data provide interesting 
anecdotal information about the effects of HT in individuals living with HIV disease. 
However, it does not provide sufficiently rigorous scientific information about the effects 
of HT in HIV disease. 
Therapeutic Touch Research 
Because there are limited peer-reviewed HT publications and HT and therapeutic 
touch (TT) are related energy-based therapies, a review of TT research is also included. 
Krieger and Kunz, a nurse and a healer, developed TT in the 1 970's .  Its origins are based 
on the ancient technique of laying on of hands, traditional eastern medicine, as well as 
quantum physics (The Burton Goldberg Group, 1 995 ; Castleman, 1 996) . Generally, the 
practitioner does not physically touch the recipient during TT. The hands are placed 2 to 6 
inches away from the body. HT is a comprehensive framework of energy-based therapies 
which subsumes the technique of TT. HT was developed after the introduction of TT into 
nursing practice and literature. It shares the same theoretical basis but is comprised of a 
wider variety of techniques ( involving both physical touch as well as working 2 to 6 inches 
away from the body) specific to particular energy imbalances or physical il lnesses and 
involves a longer, more complex certification process. According to Slater ( 1 995), who 
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developed a theory of energetic healing based on physics, energetic healing is healing that 
occurs at the quantum and 'electromagnetic levels of an individual . According to this 
theory, all energy therapies are based in the laws of physics and, fundamentally, all are 
varying techniques that elicit similar effects. 
Therapeutic touch and the relaxation response. TT has been shown to induce a 
generalized relaxation state. As described by Krieger and colleagues ( 1 979), this response 
included dilation of the vessels of the skin, decreased vocal pitch, and a subjective feeling 
of tranquility in clients undergoing TT. The most interesting finding in this small 
experiment were the electroencephalogram (EEG) findings. Generally, when the eyes are 
closed and a person is in a calm state of mind, an alpha state exists .  A normal state of 
wakeful awareness is a beta state. The participants exhibited alpha wave activity on EEG 
even though their eyes were open. When questioned, they expressed a sense of well-being. 
Despite the intriguing results of this report, there were only three participants and no form 
of scientific control was applied. 
Based on the premise that a TT encounter affects both the recipient and the 
practitioner, a more recent study evaluated the presence of the relaxation response in 
nurses performing TT (Sies, 1 994) .  The researcher recruited eight nurses who had been 
practicing TT for at least one year and measured peripheral skin temperature while they 
performed TT for at least 1 5  minutes. S ies found that 50% of the practitioners 
demonstrated a relaxation response as evidenced by increased peripheral skin temperature. 
The personal practice of meditation or other relaxing therapies was not assessed or 
controlled in the practitioners. Furthermore, half of the practitioners did not demonstrate a 
significant relaxation response. 
TT and hemoglobin. Extensive work has been done on the physiological and 
psychological effects of TT since it was introduced by Krieger in 1 974 (Quinn, 1 988) .  
Krieger ( 1 975)  demonstrated a significant increase in  hemoglobin levels in  hospitalized 
adults following TT. A convenience sample of 64 patients was treated with either TT or 
routine nursing care. There were no significant differences among baseline hemoglobin 
levels. Despite a reported increase in mean hemoglobin levels, rigor was lacking in this 
early trial . There were no operational definitions or randomization procedures and 
hemoglobin values were not included in the report . 
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TT and pain. Several trials have shown TT to decrease pain. In a quasi­
experimental trial, Keller and Bzdek ( 1 986) investigated the effects of TT on tension 
headache pain. Based on the premise that TT reduces anxiety and given there is an anxiety 
component in tension headaches, a sample of 60 healthy participants with tension 
headaches was randomly assigned to the TT intervention or a mimic TT control group. 
Each participant received a 5-minute intervention. The researchers did TT sessions and 
data collection. In the TT group, the researcher centered and entered a quiet meditative 
state, making a conscious intent to help the recipient . In the mimic TT control group, 
there was no attempt to center or reach a meditative state. The researcher performed the 
same movements as with the TT group while focusing on the mental task of subtracting 
from 1 00 by 7s. Pain levels were measured immediately prior to the intervention and 5 
minutes and 4 hours after the intervention using three subscales of the McGill-Melzack 
Pain Questionnaire. A Wilcoxon signed-rank test for differences revealed that 90% of the 
part icipants exposed to TT reported a sustained reduction in headache pain. The TT group 
experienced twice the amount of pain relief at 4 hours when compared to the control 
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group. The control group also experienced some headache pain relief, perhaps validating 
potential placebo or Hawthorne effects. This study included an adequate sample size and 
randomization to groups. However, statistical analysis was weak and the study design did 
not address potential covariates. Additionally, the researcher administered the treatments 
as well as the pain questionnaires, allowing for significant practitioner-participant effects. 
Finally, even though the practitioner consciously attempted to block any intention to help 
or direct energy during the mimic sessions, the effect of a caring presence cannot be 
excluded, especially in light of a decrease in headache pain in the control group. To this 
researcher, the TT mimic or sham control is an inadequate control condition, primarily 
because of the presence of a caring individual . The majority of the individuals performing 
the mimic sessions are nurses and although they are not trained in TT, they represent 
caring presence, rendering attribution of any detectable effects to TT difficult . Assessing 
the effects of energy therapies is at best complicated, even when controlling for 
confounding variables that potentially affect the dependent variable of interest . 
Additionally, the mechanism of action of energy therapies remains unknown. If it is actual 
energy exchange or modulation, this cannot currently be measured adequately. A no­
treatment control group is a better alternative because it removes the possibility of effects 
related to therapeutic human contact . 
Meehan ( 1 993 ) studied the effects of TT on postoperative pain in 1 08 individuals 
following major elective abdominal or pelvic surgery . Individuals were randomized into 
three groups: TT intervention, mimic TT intervention (MTT), and the standard 
intervention (SI)  of analgesic medication as needed (PRN). Pain levels were measured 
using the Pain Visual Analogue Scale (V AS) before and one hour after the assigned 
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intervention. The author identified the V AS as a widely recognized, valid and reliable tool 
for measuring acute pain. Validity of the V AS was assessed in this study by correlating 
participants' verbal pain intensity descriptors with their V AS scores. The descriptors were 
"no pain," "mild pain," "moderate pain," "severe pain," and "pain as bad as can be." 
The overall descriptor-VAS correlation was . 72. If individuals receiving TT or MTT 
requested pain medication, they were assigned a post-intervention pain score equal to their 
pre-intervention score for the purpose of statistical analysis. Using analysis of covariance, 
the SI group was found to have statistically significant reductions in pain. The TT group 
also experienced a decrease in pain but not equal to the level of reduction in the SI group. 
The MTT group did not experience any decrease in pain following their intervention. The 
participants who received TT did wait a significantly longer period of time in requesting 
additional PRN analgesia when compared with the MTT group. The authors concluded 
that TT is a useful adjunct to PRN analgesia for postoperative pain but should not be 
relied on exclusively for effective pain control . Adequate sample size, randomization 
procedures, consideration of covariates, and the researcher not playing the role of 
practitioner were strengths of this clinical trial . The use of a visual analogue scale and the 
use of a mimic TT control group were weaknesses of the study. 
Peck ( 1 997) investigated the effects of TT on pain and distress related to 
degenerative arthritis (rheumatoid or osteoarthritis) in 82 elders. Participants served as 
their own controls for a 4-week baseline period while receiving routine arthritis care 
consisting of medications, heat or cold applications, prescribed rest or exercise, physical 
therapy, chiropractic therapy, massage, and steroid injections. Following the 4-week 
baseline period, the participants were assigned randomly to receive one TT or progressive 
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muscle relaxation (PMR) session weekly for 6 weeks. Additionally, participants were 
assigned randomly to practitioners to "control for the differences in personality and 
interaction style of the practitioners" (p. 1 2 ) .  The author chose PMR as the comparison to 
avoid the limitations associated with TT sham or mimic controls. The limitations of sham 
therapy identified were nurses' anxiety related to consciously withholding a therapeutic 
treatment and a placebo effect transmitted by the nurse during a sham treatment. A total of 
45 participants received TT while 37 received PMR Two visual analogue scales were 
used to measure pain and distress before and after each session. The scales consisted of 
I O-centimeter (cm) vertical lines, with the pain scale ranging from "no pain" to "worst 
pain imaginable" and the distress scale ranging from "doesn't  bother me" to "unbearable ." 
There were statistically significant reductions in pain and distress in both groups, with the 
greatest reductions being in the PMR group . Additionally, there were clinically significant 
improvements in the participants' physical abilities during the study. Participants reported 
the ability to perform activities they had not been able to perform as well as increased ease 
in performing routine daily activities. TT was not as effective as PMR in decreasing 
arthritis pain, perhaps because of the therapeutic use of the muscles in PMR or because 
TT does not elicit as deep a relaxation response. This study included an adequate sample 
size, randomization procedures, and a researcher who did not administer TT treatments .  
Limitations include the use of visual analogue scales as the only measure of pain and 
distress and possibly random assignment of participants to practitioners. Random 
assignment of practitioners to control for practitioner effects is reasonable theoretically, 
but it differs from the usual practice of TT. The scientific benefits of randomization may 
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not outweigh the benefits of assessing TT in the context in which it is generally given and 
received in practice, i . e . ,  by a given practitioner over time. 
TT and wound healing. Wirth has conducted a series of studies on the effects of 
TT on the rate of wound healing. Following is a study representative of his work. In 1 992, 
he investigated the effects of TT on the rate of healing of skin punch biopsy wounds in 44 
healthy college students randomized into treatment and no treatment groups. A physician 
measured wound size on days 0, 8, and 1 6  using a standard direct tracing method and 
digitization system. Wounds were dressed and treated identically in both groups. The 
participants were exposed to daily 5-minute TT or mimic control sessions. The group 
treated with TT experienced significant acceleration of wound healing at days 8 and 1 6, as 
evidenced by decreased wound surface areas as compared to those in the control group. 
Adequate sample size, randomization to groups, and independent physician wound 
measurement are all methodological strengths in this as well as similar studies done by 
Wirth that have yielded similar results. The use of mimic TT in the control group would 
not appear to be a concern with the more objective and non-reactive outcome of wound 
healing. 
TT and anxiety. In multiple studies, TT has been shown to decrease anxiety (e .g . ,  
Heidt, 1 98 1 ;  Quinn, 1 984, 1 989; Simington & Laing, 1 993 ; Gagne & Toye, 1 994; Olson 
& Sneed, 1 995 ) .  Heidt ( 1 98 1 )  measured the effects of therapeutic touch on anxiety in 90 
patients hospitalized in a cardiovascular unit of a large urban medical center. An 
experimental pretest-posttest design was used with participants randomized into three 
groups consisting of S-minute sessions of TT, casual touch, or no touch. The Speilberger 
Self-Evaluation Questionnaire, a well-established measure of state anxiety was used, 
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although the reliability and validity of this instrument were not reported for Heidt ' s  study. 
Individuals who received TT experienced a statistically significant reduction in state 
anxiety. Participants did not experience a significant reduction in anxiety following the 
casual touch or no touch sessions. This was a well-designed and executed study. Sufficient 
sample size, treatment randomization, a reliable and valid instrument, and appropriate 
statistical analysis provided methodological rigor. The researcher did administer the TT 
treatments while a research assistant collected data. However, the research assistant was 
also responsible for randomization so she was not blinded to group assignments thereby 
introducing potential bias 
In a related trial, Quinn ( 1 984) found that individuals treated with a form of non­
contact TT experienced a greater decrease in state anxiety than did individuals treated 
with a mimic control intervention. This was the first TT study to employ the mimic TT 
intervention designed by Quinn Quinn was testing the "theorem that the effects of 
therapeutic touch do not depend on actual physical contact" (p. 42) .  This hypothesis was 
based on Martha Rogers' nursing theory, the Science of Unitary Human Beings. 
According to Rogers ( 1 990), people are energy fields; thus the human energy field is 
contiguous with the environmental energy field and physical contact is not necessary for 
energy exchanges. Citing Rogers' conceptual system and Heidt ' s  ( 1 984) outcome of 
anxiety reduction in cardiovascular patients following TT, Quinn conducted an 
intervention that "was identical to Heidt ' s  intervention except that in Heidt ' s  study, the 
hands were placed on the subject ' s  body" (p. 45) .  Quinn studied 60 males and females 
with cardiovascular disease in an urban medical center. Participants were randomized into 
the non-contact TT intervention group or the mimic intervention control group, which 
3 2  
consisted o f  the practitioner performing the same hand movements a s  TT practitioners but 
without attempts to center, assist the participants, attune to the condition of the 
participant, or direct energy. Following a 5-minute session, the individuals who received 
non-contact TT experienced a greater decrease in posttest state anxiety than did those in 
the control group. Quinn concluded that because physical contact was not necessary for 
TT to reduce anxiety, study findings provided support for Rogers' energetic conceptual 
system. Another potential conclusion is that many individuals are uncomfortable with 
physical touch, thus, a non-contact intervention would be less anxiety provoking. This 
study was based on a sound theoretical framework and included an adequate number of 
participants, a reliable and valid measure of state anxiety, and attention to conducting TT 
and mimic TT sessions identically. Additionally, the researcher collected data while a total 
of four nurses administered the TT and mimic TT sessions. The nurses who administered 
the mimic sessions had no prior knowledge or training in TT. 
In 1 989, Quinn conducted a second investigation testing the theory of TT as 
energy exchange. Quinn hypothesized that if TT was based on energy exchange, eye and 
facial contact should not be necessary for manifested effects. This hypothesis was not 
supported . A total of 1 53 patients scheduled for next-day open-heart surgery were 
randomized to one of three groups :  TT, a mimic control intervention (MTT), or no 
treatment, each lasting 5-minutes. The MTT was the same procedure used by Quinn in the 
aforementioned study. This intervention was judged to be indistinguishable from TT when 
observed directly by seven naive observers and 40 naive observers watching a videotape. 
During the 5-minute sessions, practitioners were asked to avoid eye and facial contact 
with participants. Measures included state anxiety, blood pressure, and pulse. There were 
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no statistically significant physiological changes among the groups. Decreases in posttest 
state anxiety scores were greatest in the TT group but also did not reach statistical 
significance. Quinn concluded that eye and facial contact may be a necessary catalyst for 
energy exchange in TT . The strengths of Quinn ' s  1 984 investigation are also found in this 
follow-up study. The question of the mechanism of action of energy therapies such as TT 
remains unanswered . 
In a double-blind, three-group experimental trial, Simington and Laing ( 1 993 ) 
found that individuals treated with TT in the form of a back rub experienced significantly 
less state anxiety when compared to individuals who received a back rub without TT. 
They studied 1 05 institutionalized elders. Because of pilot data and other evidence 
suggesting that pretest measures can bias posttest measures, the researcher chose only 
posttest measures for this study. Participants were randomly assigned to one of three 
groups :  receiving TT in the form of a back rub, a back rub without the focusing and intent 
of TT, or a back rub done by a nurse with no knowledge of TT. Participants were 
unaware of group assignment and were all treated as similarly as possible. The research 
team consisted of three individuals. One research assistant, blinded to the interventions, 
assisted participants in completing the state anxiety instrument . The other assistant, a 
registered nurse with no prior knowledge or training in TT, randomly assigned participants 
to groups and performed the back rub in one of the control groups. The investigator, a 
registered nurse and TT practitioner, administered the TT treatments as well as the second 
control group consisting of a back rub with no intention to center or direct the flow of 
energy. No significant baseline differences were found among the groups on key variables. 
The mean state anxiety score for the participants who received a back rub with TT was 
significantly lower than the mean scores in the other two groups. This investigation 
included a clearly stated theoretical framework, adequate sample size, treatment 
randomization, blinding, limited practitioner/participant bias, and a reliable and valid 
anxiety instrument . However, equivalence among groups cannot be evaluated without 
pretest measures. 
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Gagne and T oye ( 1 994) studied the effects of TT and relaxation therapy (R T) on 
anxiety reduction. A group of 3 1 hospitalized psychiatric patients were randomly assigned 
to one of two treatment conditions, TT or RT, or to the mimic TT placebo condition 
designed by Quinn ( 1 984). Participants were treated with two sessions in a 24-hour 
period. TT and mimic control sessions lasted 1 5  minutes and were administered by a nurse 
or nursing assistant . The RT intervention lasted 25 to 30 minutes and was administered by 
a chaplain, according to a commonly used technique developed by Benson. Measures 
included experienced anxiety (measured by the State-Trait Anxiety Inventory), a 30-
second frequency count of extraneous physical movement counted by research-trained 
nursing staff, and a 1 0-item questionnaire entitled, "Final Summary," assessing the 
participant ' s  confidence in the treatment and the practitioner. Average pre-treatment 
expectation of a positive outcome did not differ among the three groups. Using 
multivariate analysis of variance, a significant reduction in experienced anxiety was found 
in both the TT and RT groups, but not in the control group . The authors concluded that 
larger scientific trials are needed before TT should be used in routine in-patient psychiatric 
care, but the study provides evidence of the potential of both TT and R T to 
decrease anxiety in this population. This study was well designed including adequate 
sample size, treatment randomization, attention to practitioner-participant interaction 
effects, and consideration of covariates. 
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Olson and Sneed ( 1 995)  conducted a four-group, repeated measures experimental 
trial investigating the effects of TT on anxiety in 40 healthy professional caregivers who 
were enrolled in university-based nursing or health-related graduate programs. The 
participants were divided into high- and low-anxiety groups and further into TT or no 
treatment control groups. The effectiveness of TT in reducing anxiety as well as the 
assessment of concurrent validity of three measures of anxiety were the foci of this study. 
Anxiety was measured using two well-established anxiety measures as well as a visual 
analogue scale. The three psychometric measures (Profile of Mood States, Spielberger' s 
State/Trait Anxiety Inventory, and a visual analogue scale) were highly correlated, but 
there were no statistically significant findings related to the effect of TT. No significant 
differences were found between the treatment and control groups; however, subgroup 
sizes were too small increasing the possibility of a Type I error. 
TT and stress response. The effect of TT on stress reactivity has been examined in 
at least two trials. In  a double-blind clinical trial, Randolph ( 1 984) assessed the 
physiological response to stressful stimuli following TT in 60 healthy female college 
students. The physiological response was measured by skin conductance level, 
electromyography for muscle tone, and skin temperature. Participants were randomly 
assigned to receive non-contact TT or physical touch. Baseline measures were obtained on 
all participants, then they all watched a 1 3 -minute stressful film while the experimental 
group received TT and the control group received physical touch in the form of a nurse' s  
hands on  the participant ' s  lower back and abdomen. Those nurses performing TT centered 
36 
and attuned to the participants with the intention of therapeutically assisting the 
participant, while those nurses performing physical touch simply touched the participants 
on the lower back and abdomen. The nurses administering physical touch were not trained 
in TT techniques. Physiological response was measured again 8 minutes into the film at its 
most stressful point . Following the determination of baseline equivalence between the two 
groups, the hypotheses of the study were tested with analysis of covariance using baseline 
levels as covariates. None of the hypotheses were supported. The two groups were 
physiologically similar at baseline and both experienced significant stress in response to the 
film that was not attenuated by either of the interventions. Once again, this was a well­
designed investigation that did not demonstrate a significant effect of TT (or physical 
touch) on anxiety levels. 
Kramer ( 1 990) examined the effect of TT on the stress response in children . A 
sample of 30  hospitalized children aged 2 weeks to 2 years were "selected" over a 5-
month period and treated with either TT or casual touch. Randomization was not 
mentioned in the published report . Physiological response was assessed using a tool 
developed by the researcher for this investigation entitled "Physiological Measure of 
Relaxation in Response to Touch (PMRR T)," comprised of pulse, peripheral skin 
temperature, and galvanic skin response measurements .  The intervention was done when 
the parent was not present, usually between the hours of 6 a .m. and 2 p .m. During a 
stressful procedure, children were treated with either TT, including centering and 
intending to influence the energy field, or casual touch consisting of stroking or patting the 
child ' s  head, torso, or upper arms for 6 minutes. The PMRTT was administered 3 minutes 
and 6 minutes into the two interventions. The authors concluded TT significantly reduced 
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children' s  distress following stressful experiences, as  evidenced by more rapid and greater 
decreases in scores on the PMR TT in the children who received TT as compared to those 
who received casual touch. Findings of this study must be interpreted with caution 
because this was not a well-controlled trial . Sample size and treatment randomization were 
not mentioned in the published report . Reliability and validity of the PMRTT were not 
mentioned . Also, the researcher administered the treatments and collected the data, 
possibly introducing bias. 
TT and the grief response. At least two studies have investigated the effects of TT 
on the grief response. Quinn and Strelkaskaus ( 1 993 ) investigated the effect of TT on 
bereavement . This particular study also investigated the effect of TT on immune function 
and will be discussed in detail in a subsequent section. In a doctoral dissertation, Robinson 
( 1 995)  investigated the effects of TT on the grief experience in a convenience sample of 
22 recently bereaved adults. This investigation was based on the premise that grief 
adversely affects physical and mental well-being and perhaps TT could attenuate these 
effects .  Participants were randomly assigned to receive either TT or sham (mimic) TT. 
Each group consisted of 1 1  individuals who received three consecutive sessions. The time 
frame for the TT sessions was not reported . Additionally, it was not clear whether the 
researcher administered the TT and sham TT sessions. The Grief Experience Inventory 
(GEl) was used to assess the grief experience, but information on the reliability and 
validity of this instrument were not included in the abstract . Data were collected prior to 
the first session and following the third session, as well as at I -week and 9-weeks 
following the interventions. Participants were also asked to describe their perceptions of 
the effects of TT on the grief experience at 9-weeks. Descriptive statistics, repeated 
measures analysis of variance, and a summary of subjective responses were used to 
analyze the data. The participants who received TT experienced more favorable effects 
compared to controls on their grief processes, as evidenced by improved scores on the 
GEl as well as verbal reports of improvement in their grief responses. The author 
concluded that TT had a beneficial effect on the grief experience, but investigator bias 
cannot be ruled out in this study. 
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Qualitative explorations into TT. Three qualitative inquiries exploring the 
subjective experience of TT have been published in the literature. The knowledge gained 
in these explorations provides insight into the effects of TT as experienced by both the 
practitioners and recipients. Additionally, qualitative explorations, while not providing 
generalizable results, do provide information for theoretical consideration when 
interpreting data in similar populations as well as directions for future research. Heidt 
( 1 990) used the constant comparative method to generate a grounded theory explaining 
the experience of TT for seven nurse-recipient dyads. The researcher observed and made 
extensive notes during one TT session, then interviewed each nurse and recipient about 
their experiences. The findings were characterized by consistent descriptions of 
interviewees opening themselves up to the flow of universal life energy. There were three 
major categories of experiences: (a) opening intent, or allowing oneself to focus on 
reestablishing the movement of universal life energy; (b) opening sensitivity, involving 
assessing the quality of energy flow; and (c) opening communication, or participating in a 
healing relationship that "unblocks, engages, and enlivens" one ' s  energy flow (p. 1 80) .  
Samarel ( 1 992) conducted a phenomenological investigation into the experience of 
receiving TT. Data were generated through one unstructured interview followed by a 
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second clarifying interview of 20 individuals who had received TT. The participants' 
descriptions fell into three time-related categories: experiences before TT treatment, 
experiences during TT treatment, and experiences after TT treatment . Each category 
contained specific elements .  Prior to TT, participants described physiological needs, 
mental/emotional needs, and spiritual needs. During TT treatment, participants described 
self-awareness and other-awareness consisting of altered perceptions related to themselves 
as well as others. Following TT, participants described personal changes that lead to 
fulfillment in the physiological, mental/emotional, and spiritual realms. According to the 
author, "the lived experience of TT was described as a linear process initiated by the 
participant ' s  decision to seek treatment" (p .6S I ) . The process continued through one or 
more treatments and continued to make a difference in the participant ' s  lives. TT was 
experienced as a multi-dimensional process that fostered personal growth and well-being 
over time. 
Sneed and colleagues ( 1 997) interviewed I I  female graduate students after the 
second of two TT sessions. During data analysis, five categories emerged that described 
the lived experience of the recipients who had no prior experience receiving TT. The five 
categories were relaxation, physical sensations, cognitive activity, emotions, and 
spiritual/transcendent experiences. All participants reported being relaxed and 
experiencing physical sensations and cognitive activity during the TT sessions. Physical 
sensations included "warmth", "goose bumps," and "tingling," among others. Cognitively, 
participants thought about the process of TT and what was occurring while their eyes 
were closed. A few participants expressed emotional or spiritual experiences. Participants 
generally reported feeling "good" or "wonderful," but one participant reported feeling 
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uncomfortable being the focus of such intense attention. Four participants described 
spiritual or transcendent experiences such as feeling more centered . The authors theorized 
that perhaps "the sensations associated with TT may occur developmentally," with deeper 
experiences occurring when a recipient becomes more familiar with TT (p .  243 ) .  
The qualitative explorations done by Heidt ( 1 990) and Samarel ( 1 992) were 
appropriately designed qualitative studies with attention to rigor and trustworthiness of 
the data and findings. These explorations provide insight into the experience of giving and 
receiving TT. The third exploration involved interviews by the TT practitioner, followed 
by content analysis. The third study lacked adequate rigor and must be viewed with 
caution. 
TT and well-being In a time-series design, Giasson and Bouchard ( 1 998) 
examined the effect of TT on well-being in 20 individuals with terminal cancer hospitalized 
in a university-affiliated hospital for palliative care. Participants were assigned randomly to 
either a TT intervention group or a control group . The 1 0  participants in the treatment 
group received TT on three consecutive days while the control group experienced periods 
of rest for the same duration as the TT session ( I S-minutes) at the same time of day. 
During periods of rest, the researcher was present but focused on mathematical equations 
to avoid intentional attention to the participant . Sessions were consistently conducted I 
hour following analgesic medication. Participants completed the Well-Being Scale on day 
I for a baseline measure and before and after sessions on days 2, 3 ,  and 4. The Well-Being 
Scale is a visual analogue scale evaluating several indicators of physical and emotional 
comfort . Each of nine indicators (pain, nausea, depression, anxiety, shortness of breath, 
activity, appetite, relaxation, and inner peace) is set up on a 1 0-cm line with anchor words 
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to describe the end points of the scale, for example, "no pain" (0) to "severe pain" ( 1 0) .  
This scale demonstrated adequate internal consistency Using chi-square and i-tests, no 
significant differences were found among the groups on any demographic or medical 
variables. No significant baseline differences were found for sense of well-being and mean 
dose of analgesics or anxiolytics. Using repeated measures analysis of variance, individuals 
in the TT group experienced statistically significant increases in well-being compared to 
those in the rest period control group. Attention to methodological rigor included random 
group assignment, homogeneity evaluations of the two groups, consideration of analgesic 
and anxiolytic medications as covariates, control of environmental conditions during the 
sessions (noise, interruptions, and temperature), and adequate TT practitioner training and 
experience. The major limitations were small sample size and the potential of unconscious 
influence of the researcher/practitioner who both administered treatments and collected 
data. 
TT and immune function. The effects of TT on immune function have been 
investigated in three studies. One doctoral candidate explored the effects of TT on coping 
response and immune function in 20 HIV-seropositive males (Garrard, 1 995) .  Participants 
were matched according to age, pharmacological therapy, and CD4+ lymphocyte counts, 
then randomly assigned to either the experimental or sham (mimic) TT group . Coping 
responses were measured using the Coping Resource Inventory (CRI S), which yields a 
global score called the Coping Resource Effectiveness Score. The CRIS is comprised of 
1 5  subscales. Internal consistency of the CRI S was assessed and found to be sufficient on 
each of the subcales, with coefficient alpha scores ranging from . 84 to .97. Test-retest 
reliability yielded a high level of stability (r= 95) TT as well as sham TT was administered 
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by a single practitioner certified in TT. All sessions lasted 20 minutes; TT sessions 
consisted of a 5-minute assessment followed by 1 5  minutes of treatment in which the 
practitioner redirected the flow of energy. The sham treatment consisted of the 
practitioner entering the participant ' s  room, standing at the head of the bed, then leaving 
the room 20 minutes later without having done any TT. Participants were blinded to group 
assignment They wore sleep masks and headphones during sessions. C04+ lymphocyte 
counts and coping effectiveness were assessed at baseline and at 3, 6, and 9 weeks. The 
specific number of sessions was not specified. However, the author stated that 9-week 
measures were done 3 weeks following the cessation of sessions. Using analysis of 
variance, statistically significant increases were found at week 9 in C04+ cell counts and 
overall coping effectiveness in the participants who received TT. Findings were not 
statistically significant at weeks 3 or 6 Even with a small sample size, this study 
demonstrates strength in the areas of matching participants for potential covariates, 
treatment randomization, blinding, and the use of a reliable and valid coping instrument 
However, post-intervention C04+ cell counts were displayed in a graph so that actual 
values are not easily determined . In viewing the graph, elevations in C04+ cell counts 
appear to be modest and are not increased consistently in all participants, making it 
difficult to determine any potential clinical significance of this finding. 
Two trials investigating the effects of TT using a PNI framework have been 
published in peer-reviewed journals. Olson and colleagues ( 1 997) discovered a statistically 
significant trend toward enhanced immune function following TT in healthy college 
students experiencing the stress of upcoming graduate entrance exams. A sample of 20 
healthy medical and nursing students were randomized to the TT treatment group or the 
43 
no treatment control group. An experienced TT practitioner who was not responsible for 
data collection did TT. Measures included three psychosocial instruments (Spielberger 
State/Trait Anxiety Inventory [SST AI], the Impact of Events Scale [IES],  and the Profile 
of Mood States [POMS]), a demographic and health habits questionnaire, and 
quantification of antibody response to the Haemophilus influenzae vaccine, serum 
immunoglobulin levels ( IgG [including subclasses], IgA, IgM), and lymphocyte subsets. 
Using !-tests, differences between groups were significant for a decrease in serum IgA and 
an increase in serum IgM, but no significant differences were noted in serum IgG or its 
subclasses. Changes in lymphocyte subset assays were not significant, including CD25+ 
levels, which were measured as a correlate of interleukin-2 receptor expression. There 
were no differences between groups in levels of antibodies to Haemophilus influenzae. 
Further, statistically significant differences were not detected on any of the psychosocial 
measures. The authors cited the small sample size and the presence of confounders such as 
dietary changes during exams as possible explanations for the predominantly non­
significant findings. Additionally, the possibility that TT does not affect immune function 
must be considered. 
Quinn and Strelkauskas ( 1 993)  conducted the most comprehensive trial published 
to date on the effects of energy work using a PNI framework. They investigated the 
effects of TT on certain psychological and immunological parameters in bereaved 
individuals .  The investigators measured the effects of TT on practitioners as well as 
participants to explore the premise that energy-based techniques affect both the 
practitioner and the recipient . Despite some intriguing findings in Quinn and 
Strelkauskas' s investigation, it was not designed rigorously and included only four 
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participants and two practitioners Outcome measures included state anxiety, affect, 
effectiveness of TT treatment, time perception, and four measures of immune function, 
namely, lymphocyte subset composition; responsiveness toward foreign cel ls as shown by 
mixed lymphocyte reactivity and cell-mediated cytotoxicity; lymphocyte stimulation using 
phytohemagglutinin (PHA), concanavalin A, and pokeweed mitogen; and natural killer cell 
assays. Participants experienced a 29% average decrease in state anxiety as measured by 
the SST AI There was not a meaningful change in the anxiety scores of the practitioners, 
perhaps because their anxiety scores were very low throughout the study. In participants 
and practitioners, there were significant increases in all positive dimensions of the Affect 
Balance Scale as well as significant decreases in all negative dimensions. 
Using the Effectiveness of Therapeutic Touch Scale, the participants treated by 
one practitioner scored 54% higher than did those treated by the second practitioner. 
However, the practitioners differed in their levels of TT experience and amount of TT 
practice time per week, and the more experienced practitioner received the higher scores. 
Practitioners and participants were asked to estimate the amount of time that elapsed 
during their session as a measure of the altered consciousness that is theorized to occur 
with TT and HT. The participants treated by the more experienced practitioner perceived 
greater lapses of time, implying greater alterations in consciousness, according to the 
investigators. All participants and one practitioner experienced a decrease in the 
percentage of suppressor T -lymphocytes (CD8+). The more experienced practitioner had 
a low suppressor T-cell percentage at baseline and this finding persisted throughout the 
study. Further evidence of enhanced immune function among participants included 
improved lymphocyte responsiveness to foreign cells as well as heightened lymphocyte 
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proliferation in response to mitogens and increased natural killer cell activity. Missing 
data made it difficult to asses-s these immune measures in the practitioners. Because of 
missing data and the small sample size, it is not possible to fully interpret the data in this 
study. However, it provides a beginning for the exploration of the effects of energy work 
in the context of the PNI paradigm. 
This study exploring the effects of HT will build on and expand the strengths of 
Quinn and Strelkauskas' s  ( 1 993 ) investigation while avoiding the weaknesses of their 
work . First, the experimental design proposed here allows for extensive scientific control .  
Second, an adequate number of participants will be included. Third, HT practitioners will 
all be nurses who have completed at least Level 3 A of HT training, signifying adequate 
HT training, and will have comparable experience levels. 
Summary of HT and TT research. In a review of the state of the research on the 
effects of TT spanning 23 articles in 1 4  refereed journals, Easter ( 1 997) concluded, "the 
findings of the research indicate positive regard for the use of Therapeutic Touch. All 
research points to the need for further study in this area. Research methods used to date 
are satisfactory, but it would behoove researchers to be more rigorous in research 
methodologies to produce a truly scientific contribution to the body of nursing literature" 
(p .  1 63 ) .  The research reviewed here provides a representative view of the current state of 
the science of HT and TT research. Consistent with Easter ' s  review, the majority of the 
research yields positive outcomes for these therapies. However, frequently the 
researcher 's  conclusions are not congruent with the data presented. Additionally, Easter' s  
call for increased scientific rigor, especially i n  quantitative investigations, is corroborated 
in this literature review. If research exploring the effects and experiences of HT and TT is 
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to meaningfully contribute to the body of nursing literature, attention to appropriate 
research design and methods' are necessary. The major limitations in the research reviewed 
include inadequate sample sizes, lack of treatment randomization and control groups 
(especially in the studies published in the HT International Research Survey), possible 
practitioner-participant effects when the practitioner is also the researcher, mimic TT 
sessions used as the control condition, potentially unreliable and invalid instruments, 
underdeveloped theoretical frameworks, liberal interpretation of data, and failure to 
consider the presented theory may be wrong when confronted with inconsistent data. The 
clinical trial proposed herein involves consistency between the research questions and 
methods as well as a sound theoretical framework and adequate scientific rigor. Thus, this 
study should provide valuable information on the effects of HT in individuals with HIV 
disease . 
Well-being 
Current conceptions of well-being are based in part on Larson's ( 1 978) meta­
analytic review of trials spanning 30 years using a multiplicity of measures of affect . In 
Americans over age 60, negative life situations such as poor health were correlated 
negatively with well-being. Brook and colleagues ( 1 979) also found negative correlations 
among subjective well-being, age, and general health ratings. Monk ( 1 98 1 )  found that 
"labeling" individuals with the diagnosis of hypertension decreased psychological well­
being and asserted this may be a phenomenon in any chronic illness. 
While there is accumulating evidence that negative affect is associated with 
immunosuppression (Kemeny & Dean, 1 995),  there is relatively little research concerning 
positive affect . It may be possible to impact positively physiological variables with positive 
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affective changes in individuals with HlY disease, given that some studies have shown 
positive affective states to be associated with improved immune function and the opposite 
for negative affective states. In one set of studies, T -lymphocyte proliferative response to 
the mitogen PHA was enhanced by positive mood states and diminished by negative mood 
state (Futterman, Kemeny, Shapin, & Fahey, 1 994; Kemeny et ai , 1 994) .  In an 
exploratory study of the effects of stress and psychological status on humoral immune 
response, Snyder and colleagues ( 1 990) found that psychological well-being was 
positively correlated with postimmunization IgG levels and the opposite for psychological 
distress. A total of 89 healthy female college students were immunized with keyhole limpet 
hemocyanin (KLH). Life stress, psychological status, and serum IgG levels were measured 
immediately prior to immunization and 3 and 8 weeks following immunization. Sample 
size was calculated to be large enough to demonstrate a medium effect size. Participants 
with greater psychological well-being had significantly higher IgG levels at all three 
measurement times compared to those with lower psychological well-being. 
Several issues arise when evaluating the outcomes of trials investigating positive 
affective states such as enhanced well-being . First, empirical evidence to date remains 
inconclusive and contradictory. For example, Futterman and colleagues ( 1 994) found that 
positive as well as negative affective states enhanced NKC cytotoxicity. Second, none of 
these studies has investigated well-being as this trial seeks to do. Correlates of well-being 
such as coping effectiveness and hardiness have been investigated, but no global indicator 
of general well-being has been included . Third, many studies have been fraught with 
inadequate sample sizes and methodological flaws (McCain & Zeller, 1 996) that this trial 
avoided. Finally, none of these trials have evaluated the effects of complementary 
therapies on the PNI parameters measured in this trial . In this study, relationships among 
well-being, neuroendocrine mediation, and immune function were further investigated in 
individuals with HIV disease. 
Neuroendocrine Measures 
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Serotonin (5-HT). 5-HT is a neurotransmitter and hormone produced in the 
central nervous system (eNS) that influences mood and well-being (Miller & Keane, 
1 987) .  Neurotransmitters are signal molecules that mediate communication between the 
endocrine, nervous, and immune systems. Research indicates that serotonergic 
abnormalities are involved in the pathogenesis of anxiety and dysphoric states. Individuals 
experiencing anxiety and/or dysphoria exhibit alterations in serotonergic functioning, 
specifically, exaggerated re-uptake of 5-HT by eNS neurons. Selective serotonin re­
uptake inhibitors (SSRIs) such as fluoxetine (Prozac) have been useful in treating anxiety 
and dysphoria because they interfere with the re-uptake of 5-HT in the eNS .  Research 
into the dysphoric states associated with premenstrual syndrome (PMS) indicated 
improvement in this negative affective state with similar medications due to the release of 
central 5-HT and the prevention of its re-uptake (Brzezinski et aI . ,  1 990) Generally, 
increasing the amount of centrally circulating 5-HT lessens anxiety and elevates mood 
(Baldwin & Rudge, 1 995) .  
Serotonin is also gaining acceptance as  an immune modulator. Smith and 
colleagues ( 1 99 1 )  reviewed the role of 5-HT in immune responses. In peripheral blood, 5-
HT is localized in platelets and released at  sites of injury. Lymphocytes possess a high 
affinity binding site for 5-HT. Mast cells can also take up and release 5-HT. With injury 
or inflammation, mast cells release 5-HT which helps mediate local immune processes. 
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Further, 5-HT augments NK cell cytotoxicity directly as well as indirectly through 
monocyte stimulation and by -diminishing the suppressive activities of macrophages_ 
Basically, 5-HT is required for optimal T -lymphocyte activation as well as macrophage 
accessory function for T-cell activation (Sosroseno, 1 995 ;  Young & Matthews, 1 995) _  To 
date, research on serotonin has focused on negative affective states such as depression and 
PMS_ No research has been found investigating serotonin and positive affective states_ 
DHEA and cortisol .  It is thought that severe illness causes an adaptive 
adrenocortical shift manifested by increased cortisol and decreased DHEA concentrations 
resulting in an increase in the cortisollDHEA ratio (Parker, Levin, & Lifrak, 1 985) _  In 
HIV disease, cortisol remains elevated at all levels of infection_ There is a negative linear 
correlation between CD4+ lymphocyte counts and cortisol whereas there is a positive 
linear correlation with DHEA Additionally glucocorticoids, including cortisol, are 
associated with alterations in cytokine production and the progression of HIV disease 
perhaps because of a shift from a type 1 to a type 2 cytokine pattern as well as 
programmed cell death (Clerici et aI . ,  1 997) _ 
Recently it has been suggested that psychological stress, by virtue of increased 
cortisol and decreased DHEA, may be associated with HIV disease progression (Clerici & 
Schearer, 1 994; Jacobsen, Fusaro, Galmarini, & Lang, 1 99 1 ;  Mulder et aI . ,  1 992)_ 
Whereas cortisol stimulates HIV replication and augments humoral immune function, 
DHEA has a reciprocal effect that includes inhibition of HIV replication and augmentation 
of cellular immune function (Regel son , Loria, & Kalimi, 1 994)_  Reducing cortisol levels 
may contribute to the attenuation or reversal of disease progression_ 
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While there have been no reports concerning positive affect and cortisollDHEA it 
is postulated that enhanced welI-being may influence this ratio and thereby enhance 
celIular immune function If negative affect increases cortisol and decreases OHEA, 
thereby impairing immune function, then perhaps positive affect decreases cortisol and 
increases OHEA, thereby enhancing immune function. 
Immune Measures 
Lymphocyte subsets. T -lymphocytes may mediate important host responses to 
HIV infection including cytotoxicity and suppression of HI V as welI as pathogens 
responsible for opportunistic infections (Carr, Emery, KelIeher, Law, & Cooper, 1 996) .  
CelIular subsets designated C04+, C08+, C057+, and the mixed subset C08+/C057+ 
are useful enumerative measures because of their roles in immune dysfunction in HIV 
disease. These four were chosen because the level of C04+ lymphocyte levels is a welI 
established marker of HI V disease status and progression, and C08+, C057+ and the 
mixed subset of C08+/C05 7+ lymphocytes contribute information about numbers of 
cytotoxic immune celIs .  C08+ lymphocytes are a subset associated with cytotoxic and 
suppressor functions. C057+ lymphocytes are cytotoxic celI markers, thus the mixed 
subset of C08+IC057+ contains both suppressor and cytotoxic cells . The C04+ and 
C08+ lymphocytes are the most frequently studied of the subsets. For example, it is well 
documented that C08+ celIs possess suppressor as welI as cytotoxic functions and are the 
principle specific mediator of non-HIV virus eradication. Non-cytotoxic C08+ T -celIs 
may play a vital role in preventing HIV disease progression .  According to Levy and 
colIeagues ( 1 996), the C08+ antiviral response occurs soon after infection and is 
maintained in asymptomatic individuals .  FinalIy, alterations in cytokine production are 
associated with CD4+ and CD8+ lymphocyte subsets (Rodriguez, Yano, Eylar, & 
Yamamura, 1 997). 
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Lymphocyte proliferation. Clerici and Shearer ( 1 993 , 1 994) have extensively 
studied the progressive dysfunction of the immune system in HIV disease. Viral 
pathogenesis involves a progressive loss of T -helper cell function involving both CD4+ 
and CD8+ lymphocytes. The T -lymphocyte response to recall antigens such as tetanus 
toxoid is the first function lost, followed by loss of T -helper cell response to allogeneic­
major histocompatability complex, and finally, loss of T -helper cell reactivity to 
phytohemagglutinin(PHA) Lucey and colleagues ( 1 99 1 )  studied over 600 HIV -infected 
but asymptomatic individuals and found that peripheral blood mononuclear cells (PBMCs) 
from 34% of the individuals responded to all three stimuli, 40% were selectively 
unresponsive to recall antigens, 1 1  % responded to PHA only, and 1 5% were unresponsive 
to any of the stimuli. Progressive defects in the response to these stimuli are positively 
correlated with disease progression and a more rapid decline in CD4+ T-cell counts .  
Improvement of T -helper cell function independent of CD4+ counts has been observed in 
individuals on HIV pharmacotherapeutic protocols (Clerici etal . ,  1 992). These positive 
changes in T -helper cell function correlated with a lower incidence of opportunistic 
infections, once again independent of CD4+ counts. 
NK cell cytotoxicity. NK cel ls are large granular lymphocytes and are 
spontaneously cytotoxic to tumor and virally infected cells . Abnormalities in NK cell 
function in HIV disease include changes in cytotoxic function, cell subset distribution, 
cytopathology, and cytokine regulation (Brenner et aI . ,  1 989). Because HIV disease first 
manifests in qualitative immune dysfunction (Clerici et aI . ,  1 989), functional, rather than 
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enumerative immune measures may be more accurate indicators of disease status over the 
disease trajectory (Nott et ai:, 1 995) .  Additionally, functional indicators of immune status, 
particularly NK cell cytotoxicity, may be more sensitive to psychosocial factors than are 
enumerative immune measures (Kiecolt-Glaser & Glaser, 1 992; Schulz & Schulz, 1 992). 
However, it must be acknowledged that functional assays are performed in vitro in an 
environment that is markedly different from in vivo measures in terms of endocrine and 
other physiological influences, making it difficult to know how well these assays reflect in 
vivo cellular functioning. 
Cvtokines. According to C1erici and Shearer ( 1 993, 1 994), an immune system 
imbalance occurs in HIV -infected individuals that generally weakens the immune system 
and accelerates the progression to AIDS. They proposed that a shift from "type I "  to 
"type 2 "  cytokine regulation was a critical step in the progression of HI V infection. Type 
I regulation primarily involves the cellular immune system and type 2 the humoral immune 
system. A type I pattern enhances cytotoxic function to protect the body against infection 
by viruses and intracellular pathogens, whereas a type 2 pattern enhances antibody and 
allergic responses. Ideally, optimal function of both types of responses is desired to 
control HIV replication and disease progression. However, in some cases, cross­
regulation of these two responses fosters stimulation of one at the expense of 
inhibition of the other. Thus, as the type I response is progressively diminished in HIV 
disease, the type 2 response is enhanced and the body loses its ability to fight opportunistic 
infections (Mosmann, 1 994) .  Manipulation of the cytokine network is currently thought to 
be a potentially important strategy in the control of HIV replication and thus disease 
progression (Poli & Fauci, 1 996) 
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In this study, a type I cytokine pattern will be represented by IL-2 and TNF-a and 
a type 2 cytokine pattern will be represented by IL-4 and IL-6. Although research does 
not consistently support a type I to type 2 shift, Shearer and Clerici ( 1 993 , 1 994) have 
presented some compelling findings. For example, IL-2 and other type I cytokines ( lL- 1 2, 
IFN-y) have been shown to reduce apoptotic T-cell death as did antibodies against the 
type 2 cytokines IL-4 and IL- I O.  In contrast, IL-4 and IL- I 0 as well as antibodies against 
the type I cytokine IL- 1 2  did not prevent, and in some cases increased, cell death. Also, 
antigenic stimulation in a dominant type 2 environment resulted in an increase in the 
proportion of dying cells, whereas these cells can be rescued if antigenic stimulation 
occurs in a dominant type I environment . Finally, Clerici and Shearer ( 1 993 ) as well as 
Chehimi ( 1 994) found that adding IL- 1 2  to cultures of PMBC'  s from HIV -infected 
individuals restored cellular immune function, including NK cell activity, IFN-gamma 
production, and lymphocyte proliferation to recall antigens. 
Currently, the cause of the shift from type I to type 2 regulation as well as other 
HIV -associated immune dysfunction is not known. While it is known that medication can 
help reverse immune dysfunction in some individuals, it is not known if other therapies will 
be useful .  It was theoretically sound to suggest that therapies such as HT may support or 
augment the immune system by enhancing well-being, thereby 
increasing serum serotonin and DHEA and decreasing cortisol, and subsequently, helping 
to maintain type I cytokine regulation, inducing a shift from type 2 to type I, and/or 
enhancing cellular immune function by other mechanisms. 
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Summary 
According to Ader ( 1 992), a leading researcher and founder of the PNI field, "an 
assessment of the clinical relevance of behavioral influences on immune function requires 
strategies that follow from a conceptual model of integrated processes of adaptation and a 
multi-determined concept of health and disease" (p .  6) .  Because of its grounding in PNI, 
this study entailed that kind of research strategy. There are no reports of research 
investigating the specific treatment and outcomes outlined here. HT and the outcomes 
measured were grounded solidly in the PNI framework, and there was adequate related 
theoretical and empirical evidence to support the investigation of the effects of HT on 
well-being, serum 5-HT levels, DHEA and cortisol, and immune function. 
Chapter 3 
Research Design and Methods 
The purpose of this study was to ascertain the effects of HT on selected PNI 
parameters in HIV -infected participants. It was hypothesized that HT would increase 
participant well-being, which would increase subsequently both serotonin and DHEA and 
decrease cortisol, and ultimately enhance immune function. This purpose was addressed 
using an experimental pretest-posttest design comparing the effects of HT on selected 
psychoneuroimmunological parameters in individuals living with HIV disease. A wait-list 
crossover control group was used to enable every participant to receive treatment. 
Participants who agreed to participate voluntarily in the study were enrolled and 
randomized to (a) the wait-list control group or (b) the immediate treatment group. Time 
I measures were done immediately before the first treatment session or beginning of the 
waiting period, and time 2 measures were done immediately following the last treatment 
session or the end of the waiting period (and simultaneous start of the first treatment) .  
Immediately before the initial treatment session and immediately following the final 
(fourth) treatment session, participants completed the General Well-Being schedule 
(GWB), the Faces Scale, the Human Field Image Metaphor Scale (HFIMS), the brief 
Profile of Mood States (POMS), and the Impact of Events scale ( IES), and had blood 
drawn for 5-HT and immune measures. Additionally, immediately before and after each 
session, and 4 to 6 hours after receiving HT, the Faces Scale was completed by 
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participants. Salivary samples for DHEA and cortisol were collected by participants upon 
arising the day of data collection. There were five certified HT practitioners, each 
performing 20-25 HT treatments, for a planned study total of 1 20 treatments (30  
participants each receiving 4 treatments) . 
The target population was males living with HIV disease who met the enrollment 
criteria. Because of the small sample size and the effects of gender on neuroendocrine and 
immune measures, women were not included in this study. A sample of 30 individuals was 
recruited to receive the HT intervention. Simple random sampling was used to assign 
participants to the wait-list or immediate treatment groups. All participants had to have 
been male, at least 1 8  years of age, able to read and speak English, and deemed to be 
physically able to attend sessions (as demonstrated by Karnofsky performance scores of at 
least 60, [Appendix C, Attachment 3 ] ) . Participants could not have been taking steroids 
or immunomodulatory drugs (including cytokines, thymic derivatives, and antineoplastic 
agents, but excluding mV-related antiretroviral drugs) . Additionally, participants must 
have had a CD4+ lymphocyte count of at least 50 cells per microliter within 3 months of 
study participation in order to have immune measures drawn. Potential participants were 
screened and excluded for (a) significant psychiatric i llness, including active psychoses, 
dissociative disorders, severe or unstable depressive disorders, and organic mental 
disorders or (b) cognitive impairment, evidenced by a score of less than 20 on the 
Cognitive Capacity Screening Examination (Jacobs, Bernhard, Delgado, & Strain, 1 977 
[Appendix C, Attachment 4]) .  It was acknowledged that antiviral medications are 
immunomodulatory. Therefore, participants were excluded if there had been antiretroviral 
medication regimen changes (dose and/or drug) within one month prior to study 
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enrollment. Additionally, controlling within subject variability was controlled by ensuring 
that all participants who had antiretroviral medication changes (including dosages) 
following enrollment were excluded from the immunological analyses. Beyond these 
criteria, potential participants were not excluded on the basis of their disease status. 
Human subjects :  Recruitment, protection, and retention. Following approval of 
the study by Committee on the Conduct of Human Research of Virginia Commonwealth 
University, recruitment flyers were distributed in the Medical College of Virginia Hospitals 
Infectious Disease and the Fan Free Clinics, as well as physicians' offices. Interested 
individuals were screened and enrolled by the investigator. Participants were informed 
fully about the study in accordance with all expectations for the protection of human 
subjects. Those participants who volunteered to participate in the study were identified 
only by an arbitrary identification (10) number. A file containing the participant's name, 
informed consent document, and corresponding 10 number will be kept in a locked 
cabinet in the investigator's office and will be accessible to the investigator and dissertation 
chair only. Immediately following enrollment, participants were randomly assigned to the 
wait-list control group or the immediate HT treatment group .  To enhance retention, 
participants were paid $50 upon completion of the study. Wait-list participants were paid 
$25 at the end of the wait-list period and an additional $50 following their final HT 
session. Additionally, participants were contacted by phone each week to remind them of 
their appointments .  
Demographic Variables and Potential Cofactors 
During enrollment, pertinent demographic data were collected using a data record 
form (Appendix C) .  Additionally, enrollment procedures included data collection on two 
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critical cofactors: Centers for Disease Control (CDC) classification (CDC, 1 992) 
(Appendix C, Attachment 1 )  and the revised HIV Center Medical Staging Scale 
(rHCMSS) score (McCain et aI . ,  1 998) (Appendix C, Attachment 2). The CDC 
classification system has widely recognized clinical and research utility. It is a nominal­
level scale that rates categories of disease across three levels of clinical symptoms and 
three levels of immunological status. Clinical symptoms are categorized as Stage A for 
acute and asymptomatic infection, Stage B for non-life threatening and non-AIDS 
opportunistic illnesses, or  Stage C for AIDS-defining conditions including life-threatening 
opportunistic illnesses. The three levels of immunological status are reflected by CD4+ T­
lymphocyte levels 1 =  500 or greater, 2= 200-499, and 3 < 200 . 
Despite its acceptance and frequent use as an indicator of HIV -disease 
progression, the CDC scale provides limited information. For this reason, the rHCMSS 
was also used as a measure of HI V-disease status and symptomatology (McCain et aI . ,  
1 998) .  The rHCMSS provides a measure of  the progression of  H I  V-related 
symptomatology that is not confounded by psychiatric symptoms or immunological status. 
The original HCMSS was developed by Gorman and colleagues ( 1 992) based on 1 986 and 
1 987 CDC criteria which did not include HIV-related conditions specific to women. 
Additionally, it was tested by physician providers only. The revised version is based on 
1 992 CDC criteria, includes updated Category B and AIDS-indicator conditions, as well 
as delineated anchor definitions for progressive scoring within each of the four major 
staging categories. According to McCain and colleagues, the validity of the rHCMSS was 
assessed as part of a larger study in a sample of 1 24 individuals living with HIV disease. 
Pearson' s  correlation between the rHCMSS and the CDC classification was . 80, 
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demonstrating adequate construct validity. Validity was further supported by correlations 
between rHCMSS scores and· CD4+ count (r= - .44) and CD4+ percentage 
(r= - .62) .  
Because the sample size was limited to 30 participants, potential covariates were 
chosen carefully to reduce the confounding of excessive, redundant, or insignificant 
cofactors. Although viral load is a potential covariate in HIV disease, viral loads were not 
measured in this study because of financial limitations. Additionally, with current 
pharmacological regimens for treating HIV infection, many individuals have undetectable 
viral loads. Other potential cofactors include psychoactive drug use, excessive alcohol use, 
age, amount and intensity of physical exercise, and malnutrition, as evidenced by weight 
loss > I 0% of usual body weight . Baseline data were collected on all covariates to enhance 
clarity and accuracy of the results. However, because of the limited sample size, it was 
anticipated that the statistical model would allow inclusion of only the most critical 
cofactors of rHCMSS score and CD4+ lymphocyte counts. 
Independent Variable: HT 
HT practitioners who participated in the study had completed at least level 3A of 
HT training, signifying they had completed at least four of the five levels of HT training. 
This criterion minimized variability among treatments by ensuring that practitioners had 
similar training and extensive experience working with clients. Additionally, every attempt 
was made to select practitioners with comparable amounts of experience and practice time 
per week. HT practitioners were selected from the local pool of certified practitioners 
based on their availability to provide treatments throughout the study. Participants' weekly 
HT sessions lasted 20 to 30 minutes and included the chakra connection technique. HT 
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sessions began with the practitioner setting her intention to help the recipient . Chakra 
connection involves placing the hands on the participant's energy centers or chakras to 
assess, then balancing each of the seven major chakras (ground, sacral, solar plexus, heart, 
throat, brow, and crown). Chakra connection is a general technique that balances the 
overall energy field The format of this technique is illustrated in Appendix B and was 
followed as precisely as possible to ensure equivalence of the HT treatments. HT sessions 
were conducted in a standard, private hospital room in the General Clinical Research 
Center (GCRC) Basically, the rooms consisted of a table, chair, and adjustable hospital 
bed. 
To ensure understanding of and adherence to the HT protocol, the investigator 
met with the HT practitioners involved in this study prior to the onset of the study to 
review the protocol .  The investigator then met with practitioners following the first HT 
sessions and prior to the beginning of subsequent groups of participants (wait-list 
participants' intervention) to review the protocol . HT practitioners were asked to follow 
the chakra connection technique as it appears in the standard HT manual . Additionally, 
they were asked to perform pre- and post-treatment assessments on each participant and 
record their observations on a standard HT assessment form (Appendix B,  Attachment 1 ) . 
These assessments were used to provide insight and clarification in data analysis and 
interpretation. At the first treatment session, participants were assigned arbitrarily to 
practitioners. Following this initial assignment, practitioners continued to work with the 
same participants to the extent possible. 
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Dependent Variables: Well-being, 5-HT, DHEA, Cortisol and Immune Measures 
Psychosocial measures. Five psychosocial measures were used in this study 
including four measures of well-being as well as an illness-specific psychosocial instrument 
(included as Appendix D) to assess the immediate as well as cumulative effects of the 
intervention. The most direct measures of well-being were the General Well-Being 
schedule (GWB) and the Faces Scale. The GWB consists of 1 8  questions, whereas the 
Faces Scale is completed by circling a single face. The shorter format of the Faces Scale 
allowed assessment of well-being immediately before and after each treatment session 
while minimizing the workload of the participants. Additionally, single-item indicators 
may yield more valid data when the variable of interest is 
the participant's overall perception of an experience (Youngblut & Casper, 1 993) .  No 
studies have been reported using either of these scales in the HIV population. 
As a multi-item indicator the GWB is a comprehensive measure of well-being 
which reflects both positive and negative feelings on the six dimensions of anxiety, 
depression, general health, positive well-being, self-control, and vitality (McDowell & 
Newell, 1 996). The first 1 4  items use 6-point response scales representing intensity or 
frequency and ask questions such as, "Have you been under or felt you were under any 
strain, stress, or pressure during the last month," with answers ranging from a score of " 1 " 
for the strongest agreement (e .g . ,"Yes, almost more than I could bear or stand") to "6" for 
the strongest disagreement (e .g . ,  "Not at all") .  The final four items ask for responses using 
marks from 0 to 1 0 on a horizontal visual analogue scale to questions such as, "How 
concerned or worried about your health have you been during the past month?" Responses 
range from a low of "not concerned at all" to a high of "very concerned."  Total scores 
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range from 1 4- 1 24, with lower scores representing more distress and higher scores 
representing positive well-being Responses also can be assessed according to the six 
individual subscale scores with a range of two to four questions comprising each subscale. 
Considering the complexity of issues relating to living with HIV disease, a scale that 
encompasses multiple aspects of well-being was not only appropriate, but also necessary 
in order to achieve a valid measure of well-being. 
Monk ( 1 98 1 )  assessed the 3 -month test-retest reliability of the GWB in two 
different groups from data collected on adults aged 25-74 years who participated in the 
Health and Nutrition Examination Survey conducted from 1 97 1 - 1 974 and found 
reliabilities 0[68 and . 8 5 .  Fazio ( 1 977) reported a 3-month test-retest reliability 0[ 85 in 
a sample of 1 95 college students. Internal consistency of the GWB is consistently high, 
with Cronbach's alpha ranging from . 88  to 95 (Fazio; Himmelfarb & Murrell, 1 983) .  In 
the study conducted by Fazio, alpha coefficients were . 9 1  for 79 males and . 95 for 1 1 6 
females Himmelfarb and Murrell ( 1 983 )  reported alpha coefficients of . 92 in 1 09 older 
persons in inpatient psychiatric units and . 88  for 279 elders 
living in the community Fazio reported discriminant validity scores of .47 when the GWB 
was correlated with an interviewer' s  rating of depression, .66 with Zung's  Self-rating 
Depression Scale, and . 78 with the Personal Feelings Inventory-Depression 
The Faces Scale demonstrated an average test-retest reliability of . 70 in Andrew 
and Crandall's 1 976 test of the validity of over 30 measures of self-reported well-being in 
222 adults. In this sample, the median validity coefficient for the Faces Scale was . 82  
when tested using a multimethod-multitrait investigation in  which six aspects of  well-being 
were assessed by four methods using structural modeling to partition variance. Andrews 
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and Crandall concluded that the validity score of the Faces Scale was among the top three 
of the instruments tested . In a review of research using single-item indicators, Youngblut 
and Casper ( 1 993)  found that these measures generally yielded acceptable reliability 
estimates and performed consistently well in validity testing. According to Hurny and 
associates ( 1 996), "mood as a global concept can validly be assessed with a single-item 
scale" (p .  245) .  They asserted that single-item indicators are suitable for clinical trials 
when multi-item scales are less feasible, which is the case with measures before and after 
each treatment session. Although they emphasized that single-item scales capture only one 
aspect of a concept, this was not a major concern with this study because a 
multidimensional indicator was also being used . 
The third measure of well-being was the 1 7-item short version of the Profile of 
Mood States (POMS) (Cella et ai , 1 987) The POMS is a widely used, standardized 
measure of mood comprised of 65 items which yield the Total Mood Disturbance Score 
(TMDS) as well as six subscale scores. The short version is preferred because of its ability 
to elicit a measure of TMDS, or positive/negative affect, efficiently and accurately. The 
original I I -item brief POMS was derived by factor analysis of the full POMS from a 
sample of 6 1 9  adults with various types of cancer, then replicated in a sample of 295 
adults with lung cancer (Cella et ai , 1 987) .  In this population the brief POMS 
demonstrated a Cronbach' s alpha of . 9 1 .  Discriminant validity was supported in two 
groups of patients with specific cancers, pancreatic and gastric. Based on earlier data, the 
authors knew that scores in pancreatic cancer patients were significantly higher than those 
of gastric cancer patients, presumably because of a tumor-mediated paraneoplastic 
syndrome present in pancreatic cancer. When the data from these two subgroups were 
analyzed, the mean scores were higher in the pancreatic cancer group compared to the 
gastric cancer group. Subsequently, six positive affect items (the original 1 1  items are all 
negative affect items) were incorporated into the brief POMS to produce the current 1 7-
item scale. 
64 
The fourth measure related to well-being used in this study was the Human Field 
Image Metaphor Scale (HFIMS) The HFIMS was chosen for two reasons. First, it was 
developed based on the Science of Unitary Human Beings, a nursing theory applicable to 
HT because of its focus on humans as energy fields. Secondly, it is consistent with the 
conception of well-being as a reflection of perceived human potential (Dossey et aI . ,  1 995;  
Bradburn, 1 969). The HFIMS is a 5-point Likert-type scale consisting of25 metaphorical 
items beginning with "I feel . "  The potential range of scores on the HFIMS is 25 to 1 25 .  
The higher the score, the clearer the field image. I t  has been postulated that clear field 
images are correlated positively with knowing participation in life choices and changes, 
especially those related to health and well-being . A blurred field image corresponds to a 
passive acceptance of life experiences. 
The HFIMS is a reliable and valid measure of perceived potential and integrality. 
Psychometric properties of the HFIMS were assessed in a pilot study of 50 and a major 
study of 3 5 8  healthy adults. Final results yielded a 25-item scale with three factors that 
were labeled "expressions of clear human field," "expressions of a blurred human field 
image," and "integrality." In pilot testing the HFIMS demonstrated a Cronbach' s  alpha of 
.93 and in major testing, .9 1 .  Construct validity was assessed in both studies by correlating 
the HFIMS with the Index of Field Energy, a related but not identical instrument . 
Using the Pearson product-moment correlation, a convergent validity score of . 59 was 
found in pilot testing and . 70 in major testing. 
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An additional psychosocial measure used in this investigation was the Impact of 
Events Scale ( IES) .  The IES is a measure of illness-specific psychological distress. Mood 
is conceptualized in this study on a continuum anchored by positive and negative affect, or 
psychological well-being and distress. The IES was an appropriate measure in this clinical 
trial, in part because the other measures of well-being, while they also capture negative 
affect or distress, had not been previously tested in the HIV population. Using the IES, 
psychological distress related to living with HIV disease has been previously documented 
as avoidant and/or intrusive thought processes related to the illness ( I ronson et aI . ,  1 990; 
McCain & Cella, 1 995;  McCain, Zeller, Cella, Urbanski, & Novak, 1 996; Perry et aI . ,  
1 992) .  The IES  i s  a I S-item instrument comprised of  two subscales, intrusion and 
avoidance, that yields an index of illness-related psychological distress. It was developed 
by Horowitz, Wilner, and Alvarez ( 1 979) based on the premise that research on human 
responses to stress requires evaluation of serious life events as well as their subjective 
impact. The lES exhibits exceptional psychometric properties and is not confounded by 
physical symptoms (McCain & Cella, 1 995 ;  McCain et aI . ,  1 996) . In a sample of 66 
persons with stress response syndromes, the split-half reliability of the total scale was . 86 .  
Internal consistency of the two subscales was high, as  evidenced by a Cronbach' s  alpha of 
. 78 on the intrusion scale and . 82 on the avoidance scale. A correlation of .42 between the 
intrusion and avoidance scale signified they are associated, but do not measure the same 
dimensions of distress. Test-retest reliability was assessed in a group of 25 physical 
therapy students before and after dissection of a cadaver. Test -retest reliability of the total 
scale was r=. 87, . 89  for the intrusion subscale, and . 79 for the avoidance subscale. The 
IES contains response options indicating the frequency of distressing (intrusive or 
avoidant) thoughts over the prior 7 days. Higher scores on the subscales of intrusive and 
avoidant thinking signify higher psychological distress. 
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Physiological measures. Pulse was measured by the HT practitioners before and 
after each session as a gross indicator of physical relaxation. Biological measures included 
salivary DHEA and cortisol, serum 5-HT levels as well as PBMC proliferative response to 
PHA, NK cell cytotoxicity, lymphocyte subsets (CD4+, CD8+, CD57+, and 
CD8+/CD57+), and selected type 1 ( lL-2, TNF-a) and type 2 (lL-4, IL-6) 
cytokine levels. Serum 5-HT levels were drawn and processed by the staff of the GCRC 
Immediately following the study, frozen samples were shipped to LabCorp for testing. 
Serotonin levels were assessed using high performance liquid chromatograpy (HPLC) .  
Salivary DHEA and cortisol were collected by participants upon arising the day of 
data collection and processed by the GCRC Salivary DHEA has been validated as an 
indicator of the unbound fraction of plasma DHEA Like salivary cortisol, unconjugated 
DHEA is liposoluble and rapidly diffuses from plasma to saliva, so that salivary 
concentration is not dependent on salivary flow rate. Mean salivary DHEA has been 
reported to be 392 pmollL in healthy individuals (Lac, Lac, & Robert, 1 993 ) .  Salivary 
cortisol is a reliable indicator of the biologically active, unbound fraction of circulating 
cortisol, with correlations between cortisol in saliva and blood typically greater than .90 .  
Salivary cortisol concentrations accurately reflect changes in blood levels within two 
minutes and are not influenced by salivary flow rates (Kirschbaum & Hellhammer, 1 992). 
Expected biological variance in cortisol includes distinct circadian rhythmicity (with peak 
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values at approximately 8 : 00 a.m. and nadir around midnight) and multiple ultradian 
secretory bursts, in addition to environmental and situational reactivity (Baum & 
Grunberg, 1 995 ;  Kuhn, 1 989). However, unstimulated salivary cortisol measured at the 
time of peak circadian levels and prior to appreciable environmental influences, that is, 
immediately upon a .m.  arising, have been shown to be consistent over sampling occasions 
(Kirschbaum et aI . ,  1 990), with normal values of 1 1 - 1 5nmollL (Kirschbaum & 
Hellhammer, 1 992). Salivette (Sarstedt) sampling kits were used for saliva specimen 
collections. Cryopreserved cortisol and DHEA saliva specimens were batch-processed. 
DHEA levels were measured by radioimmunoassay (Diagnostic Products Corporation) 
and cortisol levels were measured by ELISA (Salimetrics) in the Core Laboratory of the 
GCRC. 
Lymphocyte subset assays were performed in the clinical Immune Monitoring 
Laboratory under the direction of Dr. Pamela Kimbal l .  To explore possible correlations 
among helper/inducer and suppressor/cytotoxic T -lymphocytes with well-being among 
persons with HIV disease, a number of lymphocyte subsets were examined in this study. 
specifically CD4+, CD8+, CD57+, and CD8+/CD57+.  These four were chosen because 
CD4+ lymphocyte levels are a well established marker of HIV disease status and 
progression, and CD8+, C057+ and the combined subset of C08+/C057+ lymphocytes 
may contribute information about cytotoxic immune cell functions. Although considered 
an incomplete marker, because they only mark a portion of cytotoxic cells, the C057+ 
subset is an enumerative measure of NK cells .  Standard techniques for 2- color flow 
cytometry were used (with Becton-Dickinson F ACScan flow cytometer, F ACScan 
Research Software, and monoclonal antibodies) to identify the subsets of C03+, C04+, 
C08+, and C057+ lymphocytes. 
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AU immune measures except lymphocyte subsets were done in the HIV 
Immunology Laboratory (established through a grant to Dr. Nancy McCain from the 
National Institute of Nursing Research), under the supervision of the Laboratory Director, 
Dr. Kevin Brigle. All specimens were cryopreserved and performed in batch runs to 
decrease inter-assay variability and control within-subject variabi lity. Lymphocyte 
proliferation was to be measured by stimulating lymphocytes to divide in vitro in response 
to mitogens. Phytohemagglutinin (PHA) was the mitogen chosen because it is the most 
potent mitogen of those commonly used and is consistent with the work of Clerici and 
Shearer ( 1 993, 1 994). Mononuclear leukocytes were to be incubated first with control 
medium or medium with PHA and subsequently with tritiated thymidine. The amount of 
radioactivity incorporated by PHA-stimulated cells as compared to resting cells reflects 
the level of lymphocyte proliferation (Fletcher, Klimas, Morgan, & Gjerset, 1 992). 
However, lymphocyte proliferation assays were not done. The newly standardized assay 
measuring lactic dehydrogenase release from lymphocytes did not perform reliably in our 
laboratory standardization procedures. The laboratory was not licensed to use the 
standard 3-thymidine assay. 
Using previously cryopreserved mononuclear leukocytes, NK cell cytotoxicity was 
measured using a standard 4-hour chromium release assay with NK-sensitive K562 cells 
(American Type Culture collection) as targets. NK activity levels were reported as % lysis, 
calculated from the number of patient NK cells required to lyse 20% of the Cr-Iabeled 
target cells. Thus, higher NK cytotoxic function is indicated by higher lytic units 
(Whiteside, Rinaldo, & Hebennan, 1 992) 
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In this study, standardized enzyme immunosorbent assay (ELISA) kits 
(Quantikine, R & D  Systems) for cytokine quantification were used to examine peripheral 
blood levels of selected cytokines. To test the hypothesis that enhanced well-being is 
associated with a type 1 cytokine pattern, peripheral blood levels of IL-2 and TNF-alpha 
were measured to reflect a type 1 cytokine pattern and IL-4 and IL-6 were measured to 
represent a type 2 pattern. 
Data Col lection Procedures 
Following enrollment and before the first treatment session, the participants turned 
in saliva samples collected that morning, completed the GWB, IES, POMS, HFIMS, and 
the Faces Scale and had serum 5-HT and immune measures drawn (Time I) . These 
measures were repeated after 4 weeks, at the completion of four HT sessions (Time 2) .  
Additionally, the Faces Scale was completed immediately before and after each HT session 
and again 4 to 6 hours following the session. The investigator, with the assistance of a 
GCRC nurse, administered the psychosocial instruments to all participants. HT 
practitioners did not perform any data collection except pre-and post-treatment pulse 
measurements. Blood for measurement of the physiological variables was drawn by a 
nurse in the GCRC using standard universal precautions and aseptic technique. 
Data Entry and Analysis 
Creation and formatting of the database was done by the investigator. The 
psychometric data were scored by the investigator. All data were double-entered to verify 
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accuracy. Data were entered into a spreadsheet format with pretest, posttest, and control 
dependent variable data on the horizontal axis and participant ID code on the vertical axis. 
Data were analyzed by the investigator using the SPSS 7 . 5  program. This 
statistical program allowed for data management, analysis, and presentation. Reliability of 
the well-being instruments was assessed using Cronbach' s  alpha as well as test-retest 
reliabilities using the wait-list control group data set . Construct validity was assessed 
among the measures of well-being . Baseline equivalence of the treatment and control 
groups was evaluated using stem and leaf plots to examine group differences on location, 
spread, and shape (Verran & Ferketich, 1 987) .  The stated research questions of the study 
were tested in the form of null hypotheses using multivariate analysis of covariance 
(MANCOVA) MANCOVA allowed testing the difference among the means of two or 
more groups for two or more dependent variables simultaneously, while controlling for 
one or more covariates (Polit, 1 996) Following multivariate analyses, univariate analysis 
of variance (UNIANOV A) was performed to assess the contribution of individual 
variables to the multivariate models. Additionally, correlational analyses were done to 
assess the relationships among the variables. The significance level for all statistical 
analyses was set at alpha = 05 .  
Conclusion 
HT is a potentially beneficial therapy for individuals living with HIV disease. 
Research suggests it may indirectly enhance well-being. According to the PNI framework, 
psychological states influence physiological functioning. PNI is the study of the 
interactions between the brain and neuroendocrine and immune systems. Because it is 
difficult to measure directly the potential energetic effects of HT, indirect measures of 
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integrated psychological and physiological functioning are used currently to assess its 
efficacy. For these reasons, PNI was used as the framework for this clinical trial 
investigating the effects of HT in HIV -seropositive males. The majority of research to date 
on energy-based therapies is flawed methodologically making it difficult to advocate 
incorporation of these therapies into mainstream nursing care. This clinical trial was 
designed to provide adequate scientific rigor for investigating the effects of HT on well­
being and neuroendocrine and immune measures in individuals living with HIV disease. 
This study contributes to the growing body of research in PNI as well as energy-based 
therapies. These results do not support the use of HT as it was administered in this study. 
Further research is needed before decisions can be make regarding the use of HT in HIV 
care. 
Chapter 4 
Findings 
The purpose of this randomized clinical trial was to evaluate the effects of the 
energy therapy HT on well-being and neuroendocrine and immune function in individuals 
living with HIV disease. A total of 30 males were enrolled in the study between February 
and April, 1 999. A total of 27 individuals completed the study; one participant was lost to 
follow-up and two participants withdrew following enrollment, but prior to starting the 
intervention. Recruitment continued for five months, but efforts to replace these 
individuals were unsuccessful .  Of the 27 participants completing the study, 22 received 
four 30-minute HT sessions and 5 received three 30-minute HT sessions. These five 
individuals missed one treatment session and timely attempts at rescheduling were 
unsuccessful .  The pre-established protocol allowed participants to miss one session and 
remain in the study. 
Demographic Data 
The demographic data indicated the study sample was similar to the local HIV 
population, except no women were included in this clinical trial . There were no 
statistically significant differences in the treatment and wait-list control groups on any of 
the study variables at baseline. The mean age was 4 1  years (range 2 1  to 53 ,  SD= 7 5 3 ); 
52% of the participants were African American (n= 1 4) and 48% were Caucasian (n= 1 3 ) · 
The mean number of years of education was 1 4  (range 6 to 2 1 ,  SD= 3 92). A total of 59% 
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of participants (!}= 1 6) were single, 1 9% (!}=5) were married, and 22% (!}=6) were 
divorced or separated. According to the CDC classification system, 33% (!}=9) of the 
participants were Category A, indicating they were asymptomatic; 4 1  % (!}= 1 1 ) were 
Category B, indicating they had experienced non-life threatening and/or non-AIDS 
opportunistic illnesses; and 26% (!}=7) were Category C, meaning they had experienced 
AIDS-defining conditions. The mean CD4+ lymphocyte count was 390 cells per microliter 
or 24. 2% of T-lymphocytes, with a range from 5 . 6% to 47 .3% (SD= 1 1 . 62) . The average 
rHCMSS symptomatology score was 1 9  (range 0 to 3 5, SD= 1 3 . 5 ) .  Of the 27 
participants, 23 were taking protease inhibitors. Of the remaining four participants, two 
had never been placed on antiviral medications, one was taking ddI and d4T, and one was 
taking only AZT because of multiple medication intolerances including protease inhibitors. 
Two participants had only salivary measures because pre-baseline CD4+ lymphocyte 
counts were less than 50 cells per microliter, which prohibited collecting serum samples. 
Missing Data 
Following completion of the study, approximately 4% of the data were missing, 
virtually all because of participant non-response. The investigator also erred in not 
collecting pulse measures on seven participants and occasionally missed administering 
immediate pre- or post-treatment Faces Scales. With the exception of the pulse 
measurements, the pattern for missing data was random. The majority of the participant 
non-response missing data were the Faces Scales that should have been completed by 
participants at home 4 to 6 hours following treatment . These Faces Scales were given to 
participants in a packet to be completed following each weekly HT session. They were to 
be mailed to the investigator following the final HT session. However, only 1 6  of 27 
participants returned these instruments. 
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The decision was made to replace data because in MANCOV A cases are deleted 
listwise, meaning that if a participant is missing any variable included in the model, all of 
the participant's data are deleted from the analysis. Missing data were replaced when no 
more than 30% of the data were missing on any particular variable for a given participant . 
Using the most conservative approach, missing data were replaced with a participant's 
appropriate matched score . For example, if a pretest score was missing, the individual's 
posttest score was substituted so that no change was introduced. Therefore, 
conservatively replacing the data enabled a larger sample size for analysis, but a given 
participant's outcome was not affected Although this approach potentially introduces a 
substantial conservative bias, the group's mean score was not used because of the 
relatively high variance in the data. 
Instrument Evaluation 
Reliability of four of the five well-being instruments was evaluated using 
Cronbach's alpha as well as test-retest correlations using control group data. Because the 
Faces Scale is a single-item measure, it was assessed using only test-retest reliability. The 
desired instrument reliability score = . 70 .  As shown in Table 1 ,  with the exception of the 
IES, which demonstrated low test-retest reliability, all of the instruments were internally 
consistent and stable measures of well-being in this sample. 
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Table I 
W 11 b . e - emg nstruments :  R r bT 0 e la I ltv ata 
Cronbach's alpha Test-retest correlation 
General Well-being . 90 . 70 
Schedule (GW8) 
Faces Scale . 7 1  
Profile of Mood States . 69 . 70 
(POMS) 
Human Field Image . 92 . 90 
Metaphor Scale (HFIMS) 
Impact of Events Scale . 8 5  . 54 
( IES) 
The correlation matrix illustrating the Pearson correlations for the five measures at 
baseline is presented as Table 2 .  Construct validity was demonstrated through discriminant 
and convergent validity . The instruments reflecting positive well-being (GWB, Faces 
Scale, and HFIMS) were negatively correlated with those instruments reflecting 
psychological distress (POMS and IES) .  Additionally, the instruments were positively 
correlated with each other within the aforementioned groupings. 
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Table 2 
Instrument Correlations (Sil!nificance Level) at Baseline 
GWB FACES POMS C!!=27) HFIMS IES 
(!!=2 7 )  (!!=22 ) (!!=27)  (!!=2 7 )  
GWB 1 .00 
FACES . 50 (Q= . 0 1 7) 1 .00 
POMS - .72 (Q<.OO I )  - .67 (Q= .OO I )  1 .00 
H FiMS .26 A5 (Q=.038)  - . 3 8  (Q= .O.t8) 1 .00 
-. 1 5  -. 3 2  . 3 5  - .28 1 .00 
IES 
Hypothesis Testing 
Specific research hypotheses were that HT would ( 1 )  enhance well-being, (2) 
increase levels of serum serotonin and salivary DHEA, (3 )  decrease levels of salivary 
cortisol, and (4) enhance immune function in persons with HIY disease. The effects of HT 
were first assessed using multivariate analysis of covariance (MANCOY A). Because of 
the small sample size, three separate multivariate models were created. The first model 
was comprised of the psychosocial measures (GWB, Faces Scale, POMS, HFIMS, and 
IES) .  The second model contained the physiological variables (pulse; serotonin; DHEA; 
cortisol; CD4+, CD8+, CD57+, and CD8+/CD57+ lymphocyte subsets; and NK 
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cytotoxicity) .  The third model contained the cytokines ( IL-2, TNF-alpha, IL-4, and IL-6). 
In addition to the small sample size, the cytokines were placed in a separate model because 
they were the most tentative measures of immune function. To explore further the 
relationships among the variables in this study and to guide further univariate analyses to 
investigate the significant multivariate physiological findings, correlational analyses were 
done (Table 9) .  Because of the small sample size of the physiological variables, non­
parametric Spearman's correlations were used. Following analysis of the multivariate 
models, exploratory analyses were done using univariate analysis 
of covariance (UNIANOY A) Baseline CD4+ levels and rHCMSS scores were the 
covariates used in all of the multivariate and univariate statistical analyses. Finally, to 
further evaluate the findings in this study, pre- and post-intervention means and standard 
deviations were examined to explore trends in the data. 
Multivariate Psychosocial Model 
Hypothesis 1 .  It was hypothesized that HT would enhance participant well-being. 
According to the multivariate statistical test, there were no measurable differences in well­
being in the treatment group following HT as compared to the wait-list control group 
(Table 3 ) .  There was a significant time effect, which indicated both groups changed over 
time. There was not a significant interaction effect for group by time. Because of the 
significant time effect in the multivariate model, each variable was assessed using 
univariate analysis of variance (UNIANOYA) to identify the differences that contributed 
to this finding. However, there were no statistically significant findings in the univariate 
analyses. 
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Table 3 
M f . t An I . f C  u Ivana e alvsls 0 ovanance: P h svc osoclal Model 
Effect Wilk's Lambda I! 
(dO 
Group .60 . 03 
(6, 1 2) 
Time . 42 . 3 1 
(6, 1 4  ) 
Group by Time .65  . 3 3 
(6, 1 4) 
There were three univariate tests conducted on the Faces Scale data. The Faces 
Scale was completed by participants ( 1 )  before beginning and following completion of the 
4-week HT intervention. Additionally, this scale was completed (2) immediately before 
and after each HT session as well as ( 3 )  4 to 6 hours following each HT session. The post-
intervention Faces Scale was the only well-being measure to approach a statistically 
significant change, with a trend toward higher scores at time 2 for both the treatment and 
control groups (12= .06) .  Pre- and post-intervention mean scores and comparative analyses 
for all psychosocial variables are presented in Table 4. Finally, although no significant 
change in well-being was detected following HT, there were trends in the mean scores of 
each of the instruments in the expected directions post-intervention; scores on the GWB, 
Faces Scale, and HFIMS increased and scores on the POMS and IES declined . 
Table 4 
P h . I V  . bl M SVC OSOCla ana es: ean 
G roup 
GWB Treatment 
(Range 1 4-
1 24) Wait-List 
Control 
Total Sample 
Faces Scale Treatment 
( Range 1 -7) 
Wait-List 
Control 
Total Sample 
H FIMS Treatment 
(Range 25-
1 25) Wait-List 
Control 
Total Sample 
POMS Treatment 
( Range 0-68) 
Wait-List 
Control 
Total Sample 
IES Treatment 
(Range 0-75) 
Wait-List 
Control 
Total Sample 
s cores an d 
Mean 
Pre 6·U9 
Post 69.80 
Pre 7·U8 
Post 69.75  
Pre 69. 4 1 
Post 69.46 
Immed Pre 
5 . 1 9  
Immed Post 
5 . 80 
4-6 H r. Post 
(w/lmmed 
Post) 5 . 59 
Pre 5 42 
Post 6 . 00 
Pre 4 69 
Post 6.00 
Pre 5 04 
Post 6.00 
Pre 65 .79 
Post 70.89 
Pre 55 .69 
Post 60.69 
Pre 60.93 
Post 65 . 98 
Pre 1 2 . 7 1  
Post 1 0 . 4 3  
Pre 1 3 . 3 1 
Post 9 . 85 
Pre 1 3 .00 
Post 1 0 . 1 5  
Pre 1 5 . 2 1 
Post 1 1 . 64 
Pre 2 17 0  
Post 1 8 . 46 
Pre 1 8 . 3 3  
Post 1 4 . 9 2  
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UNIANOVA 
SD F I! 
@) 
1 3 .6 1 1 . 27  .275 
5 . 74 ( I ) 
6 . 3 4  
7.40 
1 1 . 62 
6 .47 
.93  . 2 50 .623 
.95 ( I )  
1 . 3 8  . 0 1 6  . 902 
( I )  
1 . 3 8  4 08 .062 
U6 ( I )  
1 75 
1 1 5 
1 . 59  
1 . 24 
2 11 2  . 529 .477 
2 3 . 74 ( I )  
2 1 . 1 0 
2 3 . 4 1 
2 1 . 1 2 
2 3 . 74 
1 0 . 1 5  . 2 3 8  . 6 3 2  
7 . 98 ( I )  
1 0.64 
8 .45 
10 . 1 5  
7 . 98 
1 3 . 26 1 20 . 7 3 3  
9 . 2 5  ( I )  
1 6 . 50 
1 9. 4 7  
1 4 . 98 
1 5 . 1 6  
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Multivariate Physiological Model 
Hypotheses 2, 3, 4 .  Because hypothesis 4 was related to  overall immune function, 
it was included here as well as the following cytokine multivariate model. It was 
hypothesized that HT would increase levels of serum serotonin and salivary DHEA, 
decrease salivary cortisol, and enhance immune function in individuals living with HIV 
disease. In the multivariate physiological model there was a significant treatment effect 
(Table 5 ) .  Additionally, like the psychosocial model, there was a significant time effect, 
mearung both groups changed over time. However, there was not a significant group by 
time interaction effect, which indicated the presence of a treatment effect independent of a 
time effect . It must be noted that although there was a significant treatment effect, the 
small sample size rendered the analyses unstable. 
Table 5 
Multivariate Analysis of Covariance. Physiological Model 
Effect Wilk's Lambda I! 
(dO 
Group . 00 .001  
(9,2) 
Time . 03 . 0 1  
(6,7) 
Group By Time . 3 3  . 59 
(9,4) 
Because of this significant multivariate effect, each variable was evaluated using 
UNIANOV A to detect which variables contributed to the overall multivariate effect None 
of the physiological variables demonstrated significant univariate results when tested 
individually (Table 6) .  
8 1  
Trends in the mean scores and standard deviations of the variables were examined 
(Table 6) .  There was a modest decrease in the serum serotonin levels post-intervention in 
the treatment group. There was a slight post-intervention downward trend in CD8+ 
lymphocytes levels in both the treatment and control groups. Although not statistically 
significant, there was evidence of positive trends in the enumerative and functional 
indicators of NK cells . Specifically, upward trends were observed in NK cell cytotoxicity 
and there was no evidence of downward trends in CD57+ or CD8+/CD57+ levels in the 
treatment group The absence of comparative data on the cytokines prohibits examination 
of trends in the data. 
The final physiological variable in the multivariate model was pulse rate, which 
was assessed in 2 1  of the participants (the first treatment group did not have pulse 
measures because the investigator neglected to instruct the practitioners to do so). 
Although not statistically significant, there was a downward trend in mean pulse rates 
post-intervention. However, it must be noted the decreases could have been associated 
with rest alone because participants were lying down during their 20-30 minute session. 
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Table 6 
Physiological Variables: Mean Scores and UNIANOVA 
Measure- Group Mean SO r I! 
® 
S.rotonin (ng/ml) Treatment Pre 80 00 66 1 0  -152 .5 I I 
Post 73 6� 65 79 ( I )  
Wait-list Control Pre 91 33 76 77 
Post 96 67 97 00 
Total Sample Pre 85 .j.j 70 1-1 
Post 8-1 68 81 33 
OHEA (ng/ml) Treatment Pre I 5 8  70 3 65 074 
Post I 59 -19 ( I )  
Wait-list Control Pre I 56 91 
Post 1 67 83 
Total Sample Pre I 57 79 
Post I 63 67 
Cortisol (pgIdl) Treatment Pre 25 -II 748 400 
Post �-I -II ( I )  
Wait-list Control Pre 46 50 
Post 58 -15 
Total Sample Pre 38 -II 
Post -II 38  
C04+ ( % )  Trtatment Pre 2-1 4 0  1 3 28 063 804 
Post � I 1 0  1 3  -18 ( I )  
Wait-list Control Pre 2-1 02 1 0 48 
Post 1 8 03 1 0 03 
Total Sample Pre 2-1 20 1 1 62 
Post 1 9 -19 1 1 66 
C08+ (%) Treatment Pre 56 0  1 4 35 330 573 
Post 52 66 1 3 40 ( I )  
\\l.it·list Control Pre 5-1 38 1 7  � I  
Post 5 1  n 1 3  28 
Total Sample Pre 5 5 44 1 5 59 
Post 52 1 7  1 3 06 
C057+ (%) Treatment Pre 2-1 95 1 2 27 I 22 .284 
Post �4 7 1  1 0 37 ( I )  
Wait-list Control Pre 2.1 I I  8 85 
Post �9 5 7  8 96 
Total Sample Pre 23 99 1 0 41 
Post 27 2-1 9 78 
C08+/C057+ (%) Treatment Pre 22 -t6 I I 33 09-1 763 
Post 11 93 1 0 1 7  ( I )  
Wait-list Control Pre 1 8 90 8 1 0  
Post 23 98 9 36 
Total Sample Pre 20 60 9 72 
Post 2� 68 9 58 
N h: Cytotoxicity Treatment Pre 5 3 1 3 1 8  1 -18 706 
(1)1i< units) Post 6 37 5 1 9  ( I )  
Wait-list Control Pre 8 24 1 0 1 9  
Post 6 73 5 1 0 
Total Sample Pre 6 6-l 7 2 1 
Post 6 56 5 04  
Pulse (beals/min) Treatment Pre 8 7 00 8 3 1 407 532 
Post 80 0 1  9 7 1 ( I )  
Multivariate Cytokine Model 
Hypothesis 4 .  I t  was hypothesized that enhanced immune function would be 
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demonstrated by a predominant type 1 instead of type 2 cytokine pattern in the treatment 
group following HT However, there were no statistically significant findings in the 
cytokine multivariate model (Table 7) 
Table 7 
M 1 °  u t lvanate An I ° f C  alVSlS 0 kO ovanance: Cyto Ines 
Effect Wilk's Lambda J! 
(dO 
Group . 7 1  60 
(4,7) 
Time . 6 1  .29 
(4,9) 
Group By Time . 70 .47 
(4,9) 
For continuity within the data analysis procedures and to provide directions for 
future research, univariate analyses were done on each of the four cytokines; none of these 
results were significant (Table 8) .  Because of problems with dilution techniques in the 
cytokine assays, data on group means and standard deviation scores are not reported . 
Intra-individual comparisons are valid, however. 
84 
Table 8 
Cvtokines: UNlANOV A 
Cytokines .E I! 
(dO 
IL-2 (Type 1 )  . 92 . 3 5  
(I ) 
TNF -(X (Type 1 )  . 1 9 .67  
( I )  
IL-4 (Type 2 ) . 26 .62 
(I) 
IL-6 (Type 2) . 530  . 53  
(I) 
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Exploratory correlational analyses were done to assess further the relationships 
among the study variables (Table 9; significant correlations are noted with asterisks). 
There were no significant correlations between the scores on the well-being instruments 
and the physiological measures. However, a number of significant correlations were found 
among the physiological measures. There were no significant correlations found for 
serotonin, DHEA, cortisol, or IL-4. Among the significant correlations, some were logical 
and explicable, whereas others were not . As expected the subset of CD4+ helper 
lymphocytes was correlated negatively with CD8+ suppressor lymphocytes and the mixed 
subset CD8+/CD57+ .  Similarly, CD8+, CD57+, and CD8+/CD57+ were correlated 
positively. NK cytotoxicity was correlated positively with CD4+ lymphocytes and 
inversely with the CD57+ and CD8+/CD57+subsets .  The type I cytokines IL-2 and TNF­
ex were correlated positively. Both IL-2 and TNF-ex were correlated postively with IL-6, 
perhaps indicating a type 0 cytokine pattern. The correlations among the various 
lymphocyte subsets and cytokines may be explained by the fact that each cell subset 
produces multiple cytokines. 
Further exploratory univariate analyses were done by controlling baseline values 
of a variety of the physiological variables as covariates. These models were constructed 
based on the Spearman's correlational analyses as well as prior research. The only 
significant model (12= .03)  was for a decrease in post-intervention salivary cortisol while 
controlling for baseline cortisol, DHEA, CD4+ lymphocyte percentage, and the rHCMSS 
symptomatology score . 
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Table 9 
Correlational Analyses: All Psychosocial and Physiological Variables 
COH C OS 7 !  C08+ <:08+1 Cort O I l �:A 1I�2 I I A  NKcyto Sero TNF 1L-6 
CIlS7+ 
CIlH 1 00 
CIlS7+ - 33 1 00 
C1l8+ · 55 · ·  5 5 "  1 00  
C08+1 - 32 94·· 67" 1 00 
C057+ 
Cort �2 02 1.1 057 1 00 
IlHEA 02 1 0  1 2  047 - 04  1 00  
1 I�2 28 - 47- - 40 - 52- - 00 - 04 1 00 
1L-4 - 1 9  - 27 0 6  2� - 2 1 27 10  1 00 
:-IJo.:c�1o 53- - 49- - 43 - 50 25 1 0  59- - 1 3  1 00  
Stro 0 1 - 27 04 - 30 - 1 5  1 8  28 38  40 1 00 
TNF 32 - 1 5  - -'5- - 31  - 37 1 8  56- - 1 2  39 26 1 00 
1 I �6 3 7  - -Ill - 66·· - 59· ·  - 05 - U2 66-- - 26 36 07 59" 1 00  
FaCe! - 1 7  0 1  0 1  - 03 - 06 08 34 - 1 0  1 5  - 02 - 1 5  1 4  
GWB 1 6  - 1 0  1 7  03 40- - 05 1 9  20 2 1 04 - 08 08 
I l FI M S  - 09 04 - 02 05 - 30 08 1 3  - 07 - 1 3  - 03 20 - 07 
POMS 03 01 1 2  1 2  07 - 01 - 1 7  32 - I I - 1 4 - 03 1 6  
I ES - 1 6 02 07 - 0 1  - 0 1  04 - 2 7 05 - 1 5  1 0  1 7  09 
Summary 
Using a multivariate analysis approach with univariate models constructed for 
specific explorations, it was found that HT did not enhance well-being and neuroendocrine 
and immune function as measured in this sample of individuals living with HIV disease. 
There was a statistically significant treatment effect detected in the multivariate 
physiological model, but there were no significant univariate findings to explain these 
results. Additionally, the small sample size rendered the results unstable. There was a 
significant decrease in cortisol when controlling for baseline levels of cortisol, CD4+ 
lymphocyte percentage, and rHCMSS symptomatology scores. Discussion and 
conclusions related to the findings follow. 
87 
Chapter 5 
Discussion and Conclusions 
The PNI paradigm provided a holistic framework for examining interactions 
among well-being and the neuroendocrine and immune systems. This framework is 
particularly applicable in immunologically mediated diseases such as HIV disease. Using 
an experimental design and numerous controls, this clinical trial included the first global 
indicators of well-being in PNIIHIV research. Study hypotheses related to the effect of HT 
on well-being, neuroendocrine, and immune function in individuals living with HIV disease 
were rejected. While the overall multivariate physiological model was significant, 
differences in the individual variables were not significant. The findings did not support 
treatment-related changes with the exception of decreased cortisol when critical covariates 
were controlled. Although there were no other significant changes in the physiological 
variables, the multivariate physiological model was statistically significant, most likely 
because of additive effects of variables increasing or decreasing in the expected directions. 
There was a significant time effect in both the psychosocial and physiological models. 
According to the multivariate analyses, both the treatment and control groups 
changed over time. This may have occurred because of the Hawthorne effect, or simply 
because participants were happy to be participating in the study. This time-related change 
in well-being and physiological status may have existed even with the control group 
because of a placebo response related to participants being hopeful that HT would help 
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them. Additionally, participants may have been happy they were receiving money for 
participating in the study. It IS also conceivable that participants were affected by the 
caring presence of the investigator, HT practitioners, and GCRC staff. It is a common 
observation in nursing research that there is a therapeutic effect related to the nurse's use 
of self in nursing interactions. The investigator was aware of this potential 
effect and acknowledged the ultimate importance of therapeutic, humanistic interactions 
while attempting to maintain a professional, objective relationship with participants. 
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Explanations for the absence of a treatment effect are numerous and include the 
following: ( 1 )  the treatment did not work, (2) the treatment "dose" was insufficient to 
produce measurable changes in the chosen PNI-based parameters, ( 3 )  a " standardized" HT 
intervention may not be effective, (4) there was a ceiling effect related to the baseline level 
of participant well-being and immune function, ( 5 )  small sample size, and (6) the PNI­
based measures chosen may not have been sensitive enough to detect small effect sizes. It 
is must be acknowledged that HT as it was delivered in this study did not appear to affect 
well-being and immune function in these individuals living with HIV disease. 
Based on prior research, HT sessions were designed to maximize treatment effects. 
It is unlikely that the absence of a treatment effect was related to the HT practitioners 
because all of the practitioners had adequate, similar levels of training and practice 
experience. Although practitioners were given a 20-30 minute range for treatments, 
virtually all of the participants received 30-minute HT sessions. In clinical practice 
situations, HT sessions typically last 1 hour. Perhaps the duration of the session was not 
90 
long enough. Additionally, it is conceivable that changes related to HT are appreciated 
over time and were not detectable in the short 4-week course of this study. Qualitative 
explorations provide contextually grounded information for theoretical consideration when 
interpreting quantitative data in similar samples as well as directions for future research. 
Samarel ( 1 992), following interviews with 20 individuals who had received TT, reported 
that TT was experienced as a multidimensional process that fostered personal growth and 
well-being over an extended time. Although this study involved substantially longer and 
more frequent HT sessions than prior studies, it is conceivable that significant changes are 
more effectively appreciated over longer periods of time. 
There may have been a ceiling effect related to the participants' baseline well-being 
levels and immune function The baseline scores on the psychosocial instruments were 
relatively high for the measures of well-being (GWB, Faces Scale, HFIMS) and relatively 
low for the two measures of psychological distress (POMS, IES) .  The participants in this 
study were relatively young and healthy. The mean age was 4 1  years, the average 
rHCMSS symptomatology score was 1 9  with a range of 0 to 3 5 , and the average CD4+ 
lymphocyte count was 390 cells per microliter. Further, the majority of the participants 
(23 of 27) were taking protease inhibitors (PI) .  Of the remaining four participants, two 
had never needed antiretroviral medications, one had never required PI,  and one needed a 
combination of antiretrovirals but was unable to tolerate medications other than AZT. In 
responsive patients, current drug therapy including PI reduces viral load often to 
undetectable levels and increases CD4+ lymphocyte counts thereby decreasing morbidity 
and mortality, which potentially enhances well-being. 
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Because o f  the impact o n  the power of an intervention t o  demonstrate statistically 
significant changes, the small ·  sample size and missing data likely contributed to the 
findings. Larger sample sizes are needed to achieve adequate power and stabilize variance 
in the statistical tests. Finally, the PNI-based measures chosen in this study may not have 
been robust enough to detect small effect sizes. 
Well-being 
With the exception of the test-retest reliability of the IES, the five psychosocial 
instruments used in this study were found to be reliable and valid indicators of aspects of 
well-being and psychological distress. Although there was no significant change in well­
being post-intervention, there were trends in the expected directions in the post­
intervention mean scores on each of the well-being instruments, in that scores on the 
GWB, Faces Scale, HFIMS increased and scores on the POMS and IES declined . The 
increase in the post-intervention Faces Scale scores approached a significant level (12=.06) .  
The Faces Scale may have been the most sensitive measure because it  is the simplest, most 
direct subjective measure of well-being . Hurny and colleagues ( 1 996) advocated the use of 
single-item measures when assessing subjective states such as well-being and found that 
they often performed better than multi-item well-being instruments. The IES is an event­
specific measure and the only one that had been used previously in the HIV population, 
but it was not a stable measure in this sample. However, because it measures 
psychological distress in the past 7 days, there is no reason to expect that distress levels 
remain stable from week-to-week. 
Findings related to depressed mood and immune function in persons with HIV 
disease have included decreased lymphocyte proliferation to mitogens (Futterman et aI . ,  
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1 994; Kemeny et aI . ,  1 994), decreased NK cell activity (Futterman et aI . ,  1 994), and 
alterations in WBC subpopulations (Taylor, 1 995)  in depressed individuals. According to 
the literature, negative life situations such as poor health are correlated negatively with 
well-being (Larson, 1 978;  Brook et aI . ,  1 979). Additionally, individuals "labeled" with a 
chronic illness can exhibit decreased well-being (Monk, 1 98 1 ) . Clearly the theoretical 
bases of the proposed hypotheses were sound. However, the study participants 
demonstrated relatively high baseline levels of well-being and receiving HT, as it was 
delivered in this study, did not enhance levels of well-being. 
Neuroendocrine Measures 
Serotonin. HT did not elicit significant changes in serum serotonin levels; the 
possible mechanisms are unclear, but include the absence of a treatment effect (which is 
consistent with the absence of significant changes in the other physiological variables), 
incorrect theoretical propositions about the function of serotonin within the PNI 
framework, and inappropriate measurement protocols. 
A great deal remains unknown about the use of serum serotonin as a marker of 
neuroendocrine status in general and in individuals living with HIV disease in particular. 
Based on prior research, it was hypothesized that an enhancement in well-being would be 
associated with an increased amount of circulating serotonin and, subsequently, this 
increase in serotonin should augment immune function. However, there was no 
statistically significant increase in pre- to post-treatment serum serotonin levels in this 
sample. In fact, there was a trend toward a decrease in the serum serotonin levels post­
intervention in the treatment group .  
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There have been no prior published studies measuring serum serotonin as a marker 
of neuroendocrine function in the absence of neuroendocrine disease states such as 
carcinoid. There is evidence that serotonin levels in the central nervous system fluctuate in 
response to moods, but no studies were located on mood and serum serotonin levels. 
There also is no literature on the appropriate time to measure serum serotonin levels. 
Perhaps changes in serum levels occur over a longer span of time than the 4-week interval 
in this trial . It is conceivable that changes occur not in serum levels, but in central receptor 
sites. Serum serotonin levels may remain relatively stable over time in the absence of 
neuroendocrine disease. Perhaps more importantly, sustained levels of well-being may be 
necessary to increase serum levels .  The data indicate a downward trend in post­
intervention levels .  It is possible this finding correlates with an increase in receptor-laden 
serotonin or conceivably an increase in intersynaptic serotonin. Additionally, there is a 
wide normal range for serum levels (2 1 -3 2 1  ng/ml) making it more difficult to discern the 
physiological or clinical significance of changes. Finally, there is a vast variation in the 
levels intraindividually as well as across individuals. Perhaps serial levels are needed daily 
or weekly to ascertain significant changes. 
DHEA and Cortisol. Although the multivariate physiological model was not 
statistically significant, the exploratory univariate model examining cortisol was significant 
while controlling for baseline cortisol, DHEA, CD4+ lymphocyte percentage, and 
rHCMSS score. Salivary cortisol levels declined in the treatment group and increased in 
the wait-list control group .  There was no detectable change in DHEA levels post­
intervention. 
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Measurement of salivary DHEA and cortisol is established in the literature. It is 
accepted that stress and negative affective states increase cortisol and decrease DHEA 
levels. No published reports were found concerning positive affective states and 
cortisollDHEA levels .  However, it was postulated that if negative affective states 
negatively impact this ratio, then positive affective states might have a positive impact, but 
these hypotheses were rejected. 
In this study an ultrasensitive, standardized ELISA assay was used to measure 
cortisol, but the DHEA assay was the older radioimmunoassay. Perhaps the DHEA assay 
used was not sensitive enough to detect subtle changes. However, significant 
neuroendocrine changes would not be expected if those effects are predicated on 
significant changes in well-being. Perhaps perceived stress is a stronger correlate of 
cortisol and DHEA Changes in well-being may be related to responses to stress but may 
not be sufficient to affect cortisol and DHEA levels. 
Immune Measures 
Lymphocyte subsets. Four lymphocyte subset measures were included in the 
statistical analysis, CD4+, CD8+, CD57+, and CD8+/CD57+ lymphocytes. There were no 
significant changes detected in lymphocyte subset percentages following HT. A downward 
trend was observed in CD4+ lymphocyte levels in both the treatment and wait-list control 
groups. There were similar downward trends in CD8+ lymphocyte levels in both groups. 
CD57+ and CD8+/CD57+ lymphocyte levels were the same pre-to post-intervention in the 
treatment group, but the control group demonstrated upward trends in this subset . 
Acknowledging there is no treatment effect and given the trends in the data, 
perhaps HT does not increase CD4+ lymphocyte percentage, but conceivably attenuates 
the disease-related decline over time. This is purely speculative because the data did not 
support a change in CD4+ lymphocyte levels post-intervention and participants were not 
assessed longitudinally. Although there was no detectable change in the percentage of 
CD8+/CD57+ cells, there was a trend toward higher NK cell cytotoxicity . 
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NK cytotoxicity Although there is no significant change in the number ofNK cells 
as HIV disease progresses, NK cells become functionally defective (Brenner, Dascal, & 
Wainberg 1 989; Chehimi et aI , 1 992; Sirianni, Tagliaferri, & Aviti, 1 990) . In the 
univariate analysis, the change in pre- to post-intervention NK cell cytotoxicity 
approached significance (12= .06) .  This trend is consistent with the assertion that functional 
immune measures may be more sensitive than enumerative measures to psychosocial 
factors (Kiecolt-Glaser & Glaser, 1 992; Schulz & Schulz, 1 992). 
Cytokines. C lerici and Shearer ( 1 993, 1 994) proposed that a type 1 cytokine 
pattern enhances cellular immunity whereas a type 2 pattern diminishes cellular immunity 
and enhances humoral immunity. These researchers acknowledged that their theory does 
not take into account interactions among all cell types in a dynamic system. The complex 
nature of the cytokine system makes it a challenge to measure changes in cellular 
production of cytokines. With this small data set, there is no clear demarcation of type 1 
and type 2 cytokine patterns. There is essentially a type 0 pattern, indicating more normal 
immune function in these HIV -seropositive individuals than originally anticipated. 
Cytokines were the most promising, yet complicated and tenuous measures of immune 
system function in this analysis. 
Pulse. Because energy therapies are theorized to elicit the relaxation response, 
pulse was measured before and after each treatment as an indirect measure of the 
relaxation response. Participants were allowed at least 5 minutes to rest prior to pulse 
assessment . Although not statistically significant, there was a downward trend in mean 
pulse rates post-intervention. However, it must be noted the decreases could have been 
associated with rest alone because participants were lying down during their 30-minute 
HT session. 
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In summary, there were no significant changes in well-being or neuroendocrine and 
immune function following HT as it was delivered in this study. The theoretical basis for 
the research hypotheses were sound. Explanations for rejecting the proposed hypotheses 
include the true absence of a treatment effect, ceiling effects, inadequate treatment "dose, " 
small sample size, and inadequate sensitivity of the chosen PNI-based measures. Based on 
the results of this study, implications, strengths and limitations, and directions for future 
research are offered. 
Implications 
As evidenced by the findings of this study, assessing the effectiveness of HT and 
applying the results when making clinical decisions remains a challenge. This was a 
rigorous scientific investigation into the effects of HT. It was specifically proposed that 
HT had the potential to improve well-being, thereby eliciting favorable changes in the 
neuroendocrine environment and ultimately enhancing immune function. Despite positive 
results in the literature, all of the study hypotheses were rejected . 
Prior research involving energy therapies and PNI has produced some positive 
results, however many of the prior studies lacked adequate scientific rigor. This study was 
theoretically and methodologically sound and contributes significantly to the growing body 
of research in the area of energy therapies as well as PNI .  The findings of this and 
previous studies indicate there is a need for additional well-designed studies to further 
assess the efficacy of HT, which is increasingly being used in clinical practice. 
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Despite the limited statistically significant findings, each of the participants voiced 
only positive comments about the HT treatments they received . Further evidence of the 
participants' positive perceptions of the experience of receiving HT was the development 
of a bi-monthly HT program for participants who requested continued HT treatments, 
which started in October, 1 999 at a community service agency. Independent of these 
findings, one of the HT practitioners who participated in the study established this 
program with two of the other practitioners now participating as well as one of the study 
participants who now helps schedule participants. 
Strengths and Limitations 
The major strengths of this study included its holistic approach based on a PNI 
theoretical framework and its experimental investigation of the increasingly popular 
complementary therapy of HT There have been no reports of well-designed experimental 
trials on the effects of HT arising from a PNI paradigm. The psychosocial and 
physiological measures were grounded solidly in the PNI framework, both theoretically 
and empirically. The wait-list design was both ethically and scientifically sound, allowing 
treatment of all participants and comparing the influences of a short-term, cost-effective 
therapy on the subjective well-being and immune function of individuals living with HIV 
disease. As recommended by Herbert and Cohen ( 1 993) multiple indicators of immune 
function were included to increase the reliability of the characterization of the participants' 
physiological environment and, subsequently, the understanding of relationships among 
affective, neuroendocrine, and immune parameters. 
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The most significant limitation was the small sample size. A larger sample size 
would have increased power and stabilized variance in the statistical analyses. Despite the 
short duration of this study, attrition was a known threat . There were three enrolled 
participants who did not complete the study. Although this is a small number, given a total 
sample size of 30, it was a notable level of attrition ( 1 0%) Individuals living with HIV 
disease have unstable immune systems and potentially are coping with complex issues 
which may make them more likely to withdraw from the study due to illness. Participant 
enrollment continued until a total of 30 participants had been enrolled. Recruitment efforts 
continued for 5 months but additional participants were not enrolled. 
A second limitation involved the control of the HT intervention. The majority of 
the TT research presented in the literature review involved 5-minute TT interventions. The 
timing of the sessions in HT research has been more variable. Although practitioners were 
allowed 20-30 minutes for HT sessions in this study, this did not allow sufficient time for 
individualized treatment based on recipient needs. The intervention treatment time was 
less than the typical 45-60 minute sessions in actual practice. The 20-30 minute time 
restriction allowed the five HT practitioners to treat the necessary number of participants 
in a timely manner without excessive fatigue. Additionally, the same techniques were used 
with all participants. These restrictions were necessary to enhance scientific rigor but are 
not consistent with the usual practice of this therapy. While this restriction limited 
generalizability, such scientific control was necessary. Direct practice applications will 
require further research. 
Finally, this clinical trial was not longitudinal . The hypotheses tested in this study 
involved the potential effects of HT on the neuroendocrine and immune environment in 
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individuals living with HIY disease over only 4 weeks. Even if the statistical hypotheses 
had not been rejected indicating there was a significant treatment effect, limited 
conclusions could be drawn regarding the clinical significance of such short-term changes 
in the study parameters. 
Recommendations for Future Research 
Adequate theoretical and empirical evidence supported this investigation of the 
effects of HT on well-being, serum serotonin levels, DHEA and cortisol, and immune 
function in individuals living with HIY disease. Research to date on energy therapies has 
yielded primarily positive results, although further study using more rigorous methods is 
warranted. 
Recommendations for future research include well-designed experimental studies 
with adequate sample sizes. Consideration of effect size is imperative. Effect size can be 
increased with a larger sample size, more sensitive outcome measures, as well as 
considerations related to strengthening treatment effects including an increased "dose" of 
the intervention (increased frequency and longer duration of HT sessions). Additionally, 
when interpreting findings, data and conclusions must be congruent . Although it is 
appropriate to examine trends and draw inferences that contribute to understanding the 
data and developing future research, if there is no statistically significant treatment effect, 
conclusions are limited . Finally, despite prior evidence correlating affective states and 
immune function, it is still unclear whether there are significant implications for health 
outcomes in PNI-based studies. Longitudinal, outcome-based research is needed to assess 
the impact of mind-body therapies, including energy work, on the HIY disease trajectory. 
Longitudinal research investigating the effects of HT is required to assess the long-term 
impact on disease progression. 
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Based on the findings of this study, specific recommendations can be made 
regarding the choice of outcome measures in future research. The Faces Scale is a valid 
and reliable measure of well-being. It is also easy to administer and score. The use of this 
scale should be considered in future investigations involving complementary therapies and 
well-being. 
Despite the absence of a statistically significant physiological model in this clinical 
trial, there is substantial research to support continued exploration into neuroendocrine 
and immune dysfunction in HIV disease as well as interventions that potentially enhance 
immune function and impede HIV disease progression. Salivary measures of DHEA and 
cortisol are methodologically sound, cost effective, and non-
invasive measures of neuroendocrine function and should be considered in future studies. 
Serum serotonin samples are complicated to process and expensive to assay. Until clearer 
evidence is available, this may not be a good indicator of changes in the neuroendocrine 
environment . 
CD4+ lymphocyte levels are established as valid and reliable indicators of HIV 
disease status and progression and must be considered in studies involving individuals 
living with HIV disease, at least as covariates if not outcome measures. According to the 
literature, functional measures are as important as enumerative measures when assessing 
HIV disease progression. Research to date supports the use of lymphocyte proliferation 
and NK cytotoxicity as indicators of immune function in HIV disease (Clerici & Shearer, 
1 993,  1 994; Lucey et aI . ,  1 99 1 ;  Clerici, Roilides, & Butler, 1 992; Brenner et aI . ,  1 989; 
1 0 1  
Clerici et aI . ,  1 989; Nott, 1 995)  Cytokine levels are costly and complicated t o  interpret in 
a clinically meaningful way in the context of HI V disease. Nevertheless, cytokine 
production is a promising measure of immune system function There is substantial 
research to support the indirect immunoendocrine dialogue between cortisol and cytokines 
and the progression of HI V disease (Norbiato et aI . ,  1 997; DeKruyff, Fang, & Umetsu, 
1 997; B lotta, Dekruyff, & Umetsu, 1 997) . 
Finally, research is needed to foster understanding of how individuals living with 
HIV disease appraise the significance of their experiences, including the effects on their 
daily lives as well as their long-term goals and aspirations. Well-designed qualitative 
research will provide information about the experience of living with HIV disease and 
provide directions for formulating future research questions and designs. Additionally, 
qualitative explorations into the experience of giving and receiving HT may provide 
knowledge about specific outcome measures, which is imperative because the mechanisms 
of action of energy therapies remain poorly understood. 
Conclusion 
This was a well-designed interventional study of the effects of HT on well-being 
and neuroendocrine and immune function in 27 males living with HIV disease, yet all of 
the research hypotheses were rejected. Possible explanations for the lack of a treatment 
effect include that HT did not work, the lack of statistical power to detect a treatment 
effect related in part to a small sample size, and a high level of participant well-being at 
baseline, among others. Although there was no detectable enhancement of well-being and 
neuroendocrine and immune function in the participants in this study, there was no 
indication of harm and participants perceived positive benefits while receiving HT. The 
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potential impact of positive affective states on well-being has remained largely unexplored. 
This research contributes to the developing knowledge base of energy therapies. These 
results do not support the use of HT in HIV care. Further research is need before the 
decision can be made regarding the therapeutic use of HT in HIV care. 
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APPENDIX A: 
D IAGRAM OF TH E SEVEN MAJ O R  C HAKRAS 
Crown 
Forehead 
Throat 
Heart 
Base 
A. The seven major chakras 
Brennan, B.A. ( 1 987). Hands of l ight: a guide to hea l ing th rough the human energy fie ld .  New 
York: Bantam Books 
APPENDIX A :  PH YSIOLOGIC CON NECTIONS AND THE MAJOR CHAKRAS 
CHAKRA E N DOCRI NE GLAND AREA OF BODY GOVERNED 
• I - Base Adrenals Spinal column, kidneys 
• 2-Sacral Gonads Reproductive system 
• 3-Solar Plexus Pancreas Stomach, liver, GB, PNS 
• 4-Heart Thymus Heart/circ.system, vagus 
nerve 
• 5-Throat Thyroid Throat, Pulm. and G I  
• 6-Head Pituitary Lower brain, L eye, ears, 
nose, nervous system 
• 7-Crown Pineal Upper brain, R eye 
Adapted from Brennan, B .A ( 1 987) .  Hands of light: A guide to healing through the human 
energy field. New York: Bantam Books 
APPENDIX B: 
CHAKRA CONN ECTION TECHNIQUE 
Mentgen, J .  & Bulbrook, M. ( 1 995)  Healing touch level II notebook (pp. 98- 1 02).  
Carrboro: North Carolina Center for Healing Touch 
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CDC Classification Form 
Revised H I V  Medical Center Staging Scale 
Karnofs ky Performance I ndex 
Cognitive Capacity Screening Exam ination 
APPENDIX D :  Psychosocial I nstruments 
• General Well-Being Schedule (GWB) 
• F aces Scale 
• B rief Profile of Mood States ( POMS) 
• Human Field I mage Metaphor Scale (HFIMS) 
• I mpact of Events Scale ( I ES) 
APPENDIX E Consent Form 
APPENDIX F Cytokine Data 
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Client:, ___________ _ 
Date: _____ ,Session , _: _ _ 
ASSESSM ENTI FINDINGS: ENERGY TREATMENT! FINDINGS: 
APPENDIX C :  
• Data Record Form 
• CDC Classification Form 
• Revised " IV Center Medical Staging Scale 
• Karnofsky Performance Index 
• Cognitive Capacity Screening Examination 
Date of enro llrnerv ___ '--_ GROUP ________ I D CODE ______ _ 
N�e ___________________________ ___ Contact Telephone _________________ _ 
Mailing Address _____ --:-_____ -______ ------------___ ------------
-D ETACH FROM DATA RECORD HERE. Allach above identif�'ing i n formalion 10 I NFORMED CONSE:'OT DOCUMENT.-
------------...... ---------------------------------- _.----------------_._._.--_._._------------
Recru itment Source ________ __ G ROUP _____ ID CODE ______ _ 
OAT A RECORD: 
KARNOFSKY (�  60) ___ _ COGNITIYE EXAM ( �  20) ____ __ rHCMSS ___ _ C DC C LASS ____ __ 
Attachmenl I Anachment 2 Anachment 3 Attachment <I 
AGE_= _ YEARS of EDUCATION_=___ RAC E :  I =B lack. 2=H ispanic. 3 =White. 4=Other __ _ 
PARTNER STATUS :  I =Single, never married; 2=Married or Life Parmer: 3 =Divorced or Separated; 4=W idowed 
DATE OF FIRST·KNOWN HIY·[NFECTED DIAGNOSIS ___ _ 
USUAL WEIGHT ( i e .. normal weight prior to 
i l lness-related weight lossl ____ _ 
RlSK FACTORS: 
I .  Blood 5 .  Combination I and 2 
2. Homosexuallbisexual 6 .  Combination 1 and 3 
3 .  Heterosexual 7. Combination 1 and 4 
4 .  Injection 8.  Combination 2 and 4 
9 .  Combination 3 and 4 
CURRENT MEDICATION S :  (No steroids. i m m u nomodulalors, 
Stan date of current Rx _________ __ 
Circle all that apply: 
O .  None 
I .  AZT (Retrovir) 
2 .  ddC (HIYID) 
3.  ddl (Yidex) 
5 .  HC (Epivir) 
7. 
6. Nevirapine 
Protease Inhibitor 
(ALSO code 1 ·6.8) 
4.  d4T (ZeritiStavudine) 8.  Other ____________ __ 
PRE·BASE C D4 :  ( � 50 within J months FOR BLOODl 
Date Count % __ _ 
ALCOHOL USE: 
1 .  None or rarely 
., s 3 drinks/week 
3 .  s 2 drinks/day 
4. � 3 drinks/day 
5 .  Binging (i.e., excessive intake 
that occurs in irregular pattern ) 
6.  #5 ... consistent pattern of intake 
PSYCHOTROPIC DRUGS (Prescribed): 
( Descriptive) ___________________ __ 
PSYCHOACTIYE DRUG USE ( I l l icit): 
(Descriptive) __________________ _ 
FREQUENCY OF USE: 
1 .  None or rarely 
2. s 3 times/week 
3 .  Daily 
USE OF COMPLEMENT AR YI AL TERNA TIYE THERAPIES (Descriptive) _____________ _ 
EXERCISE PATTERN: 
(Descriptive) ____________________ [Occupational e�ercise may be coded as 1/2 or 1/ 3 .  depending on level of activity I 
I .  
2.  
3.  
4. 
5 .  
Minimal 
Sporadic, effortful 
Moderate aerobic ( I  unit 3 X1wk) (e.g .. one aerobic ··unit" · 20-minute cycling. 45-minule brisk walking. jogglOg < 3 miles' 
Routine aerobic (� 3 unitslwk or conditioned intense) (e.g ..  jogging � 3 miles. 5 times I week) 
Maximal aerobic or unconditioned intense (e .g  .. competitive runmng. cycling. weight training) (Not within 24 hours, 
DATA RECORD ATIACHMENT .2. 
1 993 Revised CDC Classification Svstem for HIV Infection (CDC, 1 992b) . 
CLINICAL CATEGORIES 
CD4+ T-Iympbocyte 
COUNT (A) (8) (C) 
Asymptomatic. acute Symptomatic. AIDS-indicator 
(primary) H IV or PGV not (A) or (C) conditions conditions 
( 1 )  � 500/microliter A l  B l  C l  
(2) 200-499/J.LL A2 B2 C2 
(3) <200/J.LL A3 B3 C3 
Clinical Cate20ries 
Category A consists of one or more of the conditions listed below in an adult or adolescent ( �  1 3 )  with documented HIV infection. 
Conditions listed in Categories B and C must not have occurred. 
Asymptomatic HIV infection Persistent generalized lymphadenopathy 
Acute (primary) HIV infection with accompanying il lness or history of acute HIV infection 
Category B consists of symptomatic conditions in an HIV -infected adolescent or adult that are not included among conditions 
listed in clinical Category C and that meet at least one of the fol lowing criteria: (a) the conditions are artributed to HIV infection or 
are indicative ofa defect in cell-mediated immunity; or (b)  the conditions are considered by phys icians to have a cl inical course or 
to require management that is complicated by HIV infection. Examples of cl inical conditions in category B include, but are not 
limited to: 
Baci llary angiomatosis Candidiasis. oropharyngeal (thrush) 
Hairy leukoplakia. oral Idiopathic thrombocytopenic purpura 
L isteriosis Peripheral neuropathy 
Candidiasis, vulvovaginal:  persistent, frequent. or poorly responsive to therapy 
Cervical dysplasia (moderate or severe)/cervical carcinoma in situ 
Constitutional symptoms. such as fever (3 8 .5C)  or diarrhea lasting > 1 month 
Herpes zoster (shingles). involving at least two distinct ep isodes or more than one dermatome 
Pelvic inflammatory disease, panicularly if complicated by tubo-ovarian abscess 
For c lassification purposes. Category B conditions take precedence over those in Category A.  For example. someone prev iously 
treated for oral or persistent vaginal candidiasis (and who has not developed a Category C disease), but who is now asymptomatic 
should be classified in cl inical Category B.  
Category C includes the c l in ical conditions listed in  the AIDS surveillance case definition ( l isted below). For c lassificJtion 
purposes, once a Category C condition has occurred. the person will remain in Category C. 
Candidiasis of bronchi. trachea. or lungs Candidiasis. esophageal 
Cervical cancer, invasive Cryptococcosis, extrapulmonary 
Cytomegalovirus retinitis (with loss of vision) Encephalopathy, HIV -related 
Kaposi's sarcoma Lymphoma. Burkitt's (or equivalent term) 
Lymphoma. immunoblastic (or equivalent term) Lymphoma. primary, of brain 
Pneumocystis carinii pnewnonia Pneumonia. recurrent 
Progressive multifocal leukoencephalopathy Salmonella septicemia. recurrent 
Isosporiasis, chronic intestinal (> 1 month's duration) Wasting syndrome due to HIV 
Coccidioidomycosis, disseminated or extrapulmonary Histoplasmosis. disseminated or extrapulmonary 
Cryptosporidiosis. chronic intestinal (> 1 month's duration) Toxoplasmosis of brain 
Cytomegalovirus disease (other than liver. spleen, or nodes) 
Herpes simplex: chronic ulcer(s)  (> 1 month's duration);  or bronchitis. pneumonitis, or esophagitis 
Mycobacterium avium complex or M. /cansasii, disseminated or extrapulmonary 
Mycobacterium tuberculosis. any site (pulmonary or extrapulmonary) 
Mycobacterium, other species or unidentified species. disseminated or extrapulmonary 
OAT A RECORD A IT ACHMENT a. ( I .  Interview participant 2. Check medical record) 
Revised HIV Center �edical Staging System (rHCMSS) 
Scoring Instructions: Based on history and physical examination data. but independent of CDC claSSification and immune 
� derive a numerical score between 0 and 39  to categorize an individual's HIV-specific health status. First. categorize the 
individual by one of the major stages: Asymptomatic. Minor Symptoms. Major Symptoms. or AIDS.  Second. categorize the 
severiry of symptomatology w ithin the designated stage by assigning a score from 0-9. 1 0- 1 9. 20-29. or 30-39 .  
�ote that scores are assigned for any history or current evidence of a given symptom: once a staging score has been assigned. 
it cannot decl ine on subsequent examinations. ANCHORED rN DICATORS ARE APPROXIMA TIONS ONL Y: actual scores 
may inc lude all integers and are based on c l in ical judgment. 
Range Stage: Description and Ind icators 
0-9 Asymptomatic: Phys ical symptoms may be anributed to HIV infection. but are not. in themselves. of cl in ical 
concern. 
1 0- 1 9  
20-29 
o 2 No history of symptoms 
5 ::: Minor fatigue ( less than 25% reduction 1 0  normal activity) 
9 ::: > usual U RIs  
Minor Symptoms: L imited. but c l in ically significant symptoms which are not included below (e.g . .  persistent 
generalized lymphadenopathy. oral or vulvovaginal candida. skin and nail infections or rashes. constitutional 
symptoms of lim ited duration. episodic diarrhea. fatigue with 25-50% reduction in normal activiry. Cervical 
dysplasia [erN 1 -2 1  
1 0 ::: PGL 
1 5 ::: :0; 2 symptom episodes : L ist _________________________ _ 
1 9 ::: � 3 symptom episodes : L ist _________________________ _ 
Major Symptoms: Serious physical symptoms. but not AIDS-defming conditions. inc luding the fo l lowing 
(check if  app licable):  
__ Oral hairy leukoplakia (OHL)  
__ Salmonella septicemia (once ) 
Pneumococcal bacteremia 
__ :-.light sweats > 30 days 
Fever > 30 days 
__ Pelvic int1ammatory disease ( P I D )  
__ Cervical dysplasia ( C rN 3 )  
Diarrhea > 30 days __ Peripheral neuropathy 
H. influenza bacteremia 
Weight loss > 1 0% body wt 
Fatigue > 30 days __ HerlJes zoster 
__ Id iopathic thrombocytopenia pUrlJura I ITP) 
Other: _______________________________________ _ 
20 ::: :0; 2 symptom episodes 
25 ::: Recurrent major symptom episodes 
29 ::: ChrOniC andlor multiple major symplOm episodes 
30-39 AIDS: Any AIDS-indicator condition. inc luding the fol lowing (check if app licable): 
__ Candidiasis, esophageal or pulmonary 
__ Coccidioidomycosis 
(disseminalcd [ds1 or extrapulmonary [ep) )  
__ Cryptococcosis (ep) 
__ Cryptosporidiosis. chronic intestinal 
__ Cytomegalovirus (not liver. spleen. or nodes) 
__ Encephalopathy 
__ Histoplasmosis (ds. ep) 
__ HerlJes simplex 
(chronic, esophagus, pulmonary) 
Isosporiasls. chronic intestinal 
MAC. M. kansasii or other (ds. ep) 
M.  tuberculosis. any site 
Pneumocystis cartnii pneumonia ( PCP )  
__ Recurrent pneumonia 
__ Progressive mulufocal leukoencephalopathy 
__ Recurrent Salmonella septicemia 
__ Toxoplasmosis of brain 
__ Wasting syndrome 
Malignancy, SPECIFY: _ KS _lymphoma_invasive cer. lcaJ 
30  ::: � 2 AIDS-indicator i l lness episodes andlor conditions of limited severity 
35 ::: Recurrent indicator conditions 
39 ::: Chronic andior multiple opportUniStiC Intectlons 
C McCain. Lyon. Higginson. Senle. &: F , ,"cr d96 
DA T A RECORD A IT ACHMENT J 
KARNOFSKY PERFOR.J'v1A;\CE rNDEX 
DEFrN lTION 
Able to carry on normal activity 
and to work. No special care 
is needed. 
Unable to work. Able to live at home. 
care for most personal needs. but 
a varying amount of assistance 
is needed. 
Unable to care for se lf. Requires 
equivalent of instirutional or 
hospital care. Disease may be 
progressing rapidly. 
C RlTERlA 
1 00 Normal: no complaints: no evidence of disease 
90 Able to carry on normal activity: m inor signs 
or symptoms of  disease 
80 Normal activity w ith effort: some signs or 
70 
60 
s: mptoms of  disease. 
Cares for se lf. but unable to carry on normal 
act ivity or to do active work 
Requ ires occasional assistance. but is able to 
care for most personal needs 
....;�'--______________ = I'I/ot eligible 
50 
40 
Requires cons iderable assistance and 
frequent medical care 
Disabled: requires special care and assistance 
3 0  Severe ly disabled: hospitalization is indicated 
aithough death not imminnent 
20 Very sick: hospital ization necessary; active 
supportive treatment necessary 
1 0  \loribund: fatal processes progressing rapidly 
o Dead 
Kamofsky. D . A  . .  Abelmann. W.H . •  Craver. L .F . . & Burchenal. 1 .H .  ( 1 948) .  The use of the nitrogen mustards in the 
pall iative treatment of carcinoma. Cancer. I, 634-656. 
DATA RECORD ATTACHMENT" 
COGNITIVE CAPAC ITY SCRE EN rNG EXAM[}.;A TlON 
Instructions' Check items answered correctly. Write incorrect or unusual answers in space provided. I f  necessary. urge 
patient once to complete task. Introduction to patient " I  would l ike to ask you a few questions. Some you wil l  find very 
easy and others may be very hard. Just do your best ."  
CSE C L rNICAL JUDGMENT TO ASSESS :  (REruRN TO THESE ITEMS I F  SCORE < 20 OR QUESTIONABLE.)  
I )  What day of the week is this? 
2) What month" 
3 )  What day o f  month? 
4) What year? 
5 )  What place i s  th is? 
6) Repeat the numbers 8 7 2. 
7) Say them backwards. 
8 )  Repeat these numbers 6 3 7 
BEGrN HERE WITH SPEC IFIC ITEMS, U P  TO TOTAL OF 20 POrNTS 
9) Listen to these numbers 6 9 4. Count I through 10 out loud. then repeat 6 9 4 .  ( Help if needed.)  
1 0) Listen to these numbers 8 I 4 3 .  Count I through 1 0  out loud. then repeat 8 I � 3 .  
I I ) Beginn ing with Sunday, say the days of the week backwards. 
1 2 )  9 .. 3 is 
1 3 ) Add 6 (to the previous answer or "to 1 2") .  
I �) Tak� away 5 ("from 1 8" ) .  
REPEA T THESE WORDS A FTER ME AND REMEMBER THEM. I wi l l  ask for them later: HAT. CAR. TREE. 
TWENTY ·SIX.  
1 5 ) The opposite of fast is slow. The opposite of up is __ . 
1 6) The opposite of large is __ . 
1 7) The opposite of hard is __ " 
1 8 ) An orange and a banana are both fruits. Red and blue are both 
1 9 ) A penny and a dime are both __ . 
20) What were those words I asked you to remember? (HA T) 
22) (TREE) 
24) Take away 7 from 1 00, then take away 7 from 
what is left and keep going: 1 00 - 7 is 
25)  M inus 7 (26) M inus 7 
27) Minus 7 (28) M inus 7 
29) M inus 7 (30) M inus 7 
OR 
(2 1 )  (CAR) 
(23 ) ( TWENTY·SIX) 
Spell WORLD backwards 
( inten·iewer spell W-O-R-L-D) 
Score I po int for each lener: 
(24) D (26) R 
(25) L (27) 0 
(28) W 
EACH ITEM COUNTS A S  ONE POrNT; TOTAL CORRECT MUST B E  GREA TER THAN 1 9 .  (Maximum score = 30)  
Jacobs e t  at. ( 1 977). Annals of Internal Medicine. 86, 40·�6. 
APPENDIX D :  
G E NE RA L  WELL-BEING SCHEDULE 
McDowell, I .  & Newell, C.  ( 1 996) . Measuring health: A guide to rating scales and 
questionnaires. 2nd ed. New York: Oxford University Press 
These are q uestions about how YOll ree l  and how t h i ngs have been go i ng w i th you .  For 
each questions. mark (X) beside the answer which best applies to you. 
1 .  How have you been feel ing in general? (dur ing the past month)  
1 . --
2. --
3 .  
4 .  --
5 .  --
6. 
In excel lent spirits 
I n  very good spirits 
I n  good spirits mostly 
I have been up and down in spirits alot 
In low spirits mostly 
I n  very low spirits 
2 .  Have you been bothered b y  nervou sness or  your " nerves" ,? ( d ur ing the past month) 
--
--
--
--
--
--
l .  
2.  
.., J .  
4. 
5 .  
6.  
Extremely so--to the point  where I c o u l d  n ot work or take care 
of things 
Very muc h so 
Quite a bit 
Some-enough to bother me 
A l ittle 
Not at al l 
3 .  Have you been i n  firm control of your beh:n· i or. thoughts. � l11o t i ons.  O R  fee l i ngs .) 
( durin g  the past month) 
1 .  Yes. definitely so --
2 .  Yes. for the most pan --
3 .  General ly  so --
4 .  Not too well --
5 .  No, I am somewhat d isturbed --
6. No, I am very disturbed --
4. Have you felt  so sa d. d iscouraged, hopeless. or had so many problems that you 
wondered if anything was worthwhi le? ( dur i ng the past month) 
--
--
--
--
--
--
1 .  
2.  
3.  
4.  
5 .  
6. 
Extremely so--to the point that I have j ust about g i ven up 
Very much so 
Quite a bit 
Some--enough to bother me 
A l i tt le  bit 
Not at al l  
5 .  Have you been under o r  fe lt  you were under any stra in .  stress. or  prcssurl!·.' ( duri ng 
the past month) 
1 .  Yes--a lmost more that I could bear or stand --
2.  Yes--quite a bi t  o f  pressure --
3 .  Yes--some. more than usual --
4.  Yes--some, but  about usual --
5 .  Yes"'-a l ittle --
6 .  Not at al l --
6.  How happy , sat isfied.  or p l eased have you been wi th  your  pl!rsonal l i fe')  ( d uri ng the 
past month) 
1 .  Extremely happy--could not have been more satisfied or  --
pleased 
2.  Very happy --
3 .  Fairly happy --
4.  Satisfied--pleased --
5 .  Somewhat d issatisfied --
6 .  Very d i ssatisfied --
7. Have you have any reason to wonder i f  y o u  v"l!re losing ynur m i nd.  or los ing  
control over the \vay you act .  tal k. think. fee l .  or o f  your memory" (dur ing the  past 
month) 
1 .  Not at a l l  --
2. Only a l ittle --
.. Some--but not enough to be concerned or worried about J .  --
4 .  Some and I have been a l i tt le concerned --
5 .  Some and I am qui te concerned --
6. Yes, very much so and I am very concerned --
8 .  Have y o u  been anxious. worried. o r  upset? ( during the past month ) 
\ .  Extremel y  so--to the po i nt o f  being s ick or a l most s i c k  --
-- 2.  Very much so 
3 .  Quite a bit --
4.  Some--enough t o  bother  m e  --
5 .  - A little bit --
6. Not at all --
9.  Have you been waking up fresh, and rested? (dur ing the past month) 
1 .  Every day --
2.  Most every day --
3 .  Fairly often --
4.  Less than half the time · --
5 .  Rarel y  --
6.  None of the time --
1 0 . Have you been bothered by any i l l n\.!ss. bod i l y  d i snrder .  pa ins .  l) r k:'lrs ahout your 
health? ( d uring the past month ) 
1 .  All the time --
2. Most of the time --
3 .  A good bit o f  the time --
4 .  Some of the time --
5 .  A little o f  the time --
6 .  None of the time --
I I .  Has your daily l i fe been fu l l  of  things that wert! interest ing  to y o u ': ( dur ing  the past 
month) 
I .  All  the time --
2 .  Most of the time --
3 .  A good bit of the time --
4 . Some of the time --
5 .  A litt le o f  the time --
6.  None of the time --
1 2 . Have you fe l t  down-hearted and b l ue? ( during the past month ) 
I .  A l l  the time --
2.  Most of the time --
3 .  A good bit  o f  the time --
4 .  Some o f  the time --
5 .  A l i ttle o f  the time --
6.  None of the time --
1 3 .  Have you been feel ing emot ional l y  stab le and sure o f  yourse l f')  ( d uring the past 
month) 
I .  A l l  the time --
2 .  Most of the time --
3 .  A good bit of the time --
4. Some of the time --
5 .  A l ittle o f  the time --
6 .  None of the time --
1 4 . Have you felt tired. worn out. used-up. or t!x hallstcd') ( d uring the past month) 
1 .  All  the time --
2.  Most of the time --
... A good bit of the time J .  --
4 .  Some of the time --
5 .  A little of the time --
6 .  None of the time --
For each o f  the four scales belo\\". note that the words :.It each end o f  the 0 to 1 0  scale 
describe opposite feelings. C irc l e  :.Iny number along the bar which sl!ems c l osest to how 
you generally felt during the past month.  
1 5 . . How concerned or worr ied about your HEA L TH have you been? ( durin g  the past 
month) 
0 1 2 3 4 5 6 7 8 9 1 0  
I I , I , I I I I I I 
Not Very 
concerned concerned 
at all 
1 6. How RELAXED or TENSE has you been? ( during the past month) 
o I 
, 
Very 
relaxed 
2 3 4 5 6 7 8 9 1 0  
I I , I I I I I 
Very 
tense 
1 7 . How much ENERG Y .  P E P .  V I TA L I TY ha\ e you fe l t'} ( d uri ng the past month)  
0 1 2 ... 4 5 6 7 8 9 1 0  J 
, , , I , I I I I I I 
No energy Very 
AT ALL, ENERGETI C .  
l istless dynamic 
1 8 . How D EPRESSED or C HE E Rf U L  have you been ) (during the past month)  
o 
, 
1 
, 
Vory . ' . .  
depressed 
2 3 4 5 6 7 8 9 1 0  
, I I , I I I I 
Very 
cheerful 
GEN ERAL WELL-BEING INSTRUMENTS: FAC ES SCALE 
©QOQQGQ 
A 8 C 0 E F C 
Andrews, F. & Withey, S .  ( 1 976). Social indicators of we l l -he i ng. New York: P lenum 
APPENDIX D 
H uman Field I mage Metaphor Scale 
Please read each of the following metaphors and indicate how you feel at the moment. C heck the 
box that best describes how you identify with each statement. If you do not identify with the 
statement. check the box under, "do not identify". If you identify strongly with the statement. check 
the box under "strongly identify". There are no right or wrong answers. 
I Feel ... 
1 .  free as a bird. 
2. one with the universe. 
3. like an eternal song. 
4. like a melody. 
5. like a tree in winter. 
6. like a fenced in yard. 
I .  like a symphony. 
8. like a ray of light. 
9. like a bird in a cage. 
10 .  like an ocean breeze. 
1 1 . like a kite with no wind. 
12 .  one with the world. 
1 3. like a ray of hope. 
1 4. like a worn out shoe. 
1 5. like I can touch the stars. 
16. like a fragrance on the wind. 
1 i. like I 'm s tanding on the 
highest mountaiJI. 
18 .  like ripples on a pond. 
19.  like a free spirit 
20. like a new pair of skates 
2 1 .  like a tree in springtime. 
22. like a garden in spring. 
23. like an artist with a brush 
24. like I can see forever. 
25. like my hands are tied. 
Do �ot 
I dentify 
Slightly 
I de ntify 
Moderately 
I dentify 
Strongly 
Identify 
Totally 
I dentify 
----, ---, ----, ----, ---
----, ---, _____ ,1 ___ ,----
____ ----_. _----, _____ ,1 __ -
----, ------' --_ . _____ .1 __ -
____ _ ___ ______ f _____ , __ _ 
___ �/ _____ f ____ _____ ___ _ 
____ f ___ ____ ____ f ___ _ 
____ f _____ ______ _ ____ _ __ _ 
____ .1 ___ , ------ -----' ---
____ ,f ___ ,f ____ _____ _ __ _ 
---� _____ ,I ___ �/ _____ _ ---
____ f ___ ____ I ____ ----'f ___ _ 
____ f ___ f ___ , ____ _ __ _ 
____ ,f f _____ , ___ ,f __ _ 
___ � ______ f f ___ __ 
APPEND IX D 
Brief Poms 
Below � a list of words that describe feelings people have. Please circle the number that best 
describes how you have been feeling during the oast week. including today. 
Not At A Moderately Quite Extremely 
All Little A Bit 
I .  Unhappy -0 1 2 3 4 
2. Energetic -0 1 2 3 4 
3. Sad 0 1 2 3 4 -
4. On Edge -0 1 2 :3 4 
5. Carefree 0 - 2 :3 4 
6. Blue 0 1 2 :3 -! -
7.  Uneasy -0 1 :2 :3 -! 
8. Cheerful 0 1 2 :) -! -
9. Discouraged 0 - 1 2 3 4 
10 .  Miserable 0 - 1 2 3 4 
I I . Relaxed 0 - 1 2 3 4 
12 .  Muddled -0 1 :2 3 4 
1 3. Gloomy -0 1 2 3 4 
1 4. Alert ° 1 :2 :3 4 -
1 5. Weary -0 1 2 3 4 
1 6. Bewildered _0 1 2 :3 4 
1 7 .  Ready to fight _0 1 2 3 4 
my illness 
IMP ACT OF EVENT SCALE 
Below is a list of comments made by people with HIV - infection or AIDS. Please check the appropriate 
colUmn to indicate how frequently these comments were true for you durini the past 7 dan. If they did 
not occur during that time, please mark the " not at all" column. 
- ('1 - " 
� E 
... � 
. -... � � :; .. 
... � t: !I .. r:: i � 0 "'" � "" 
I .  [ thought about it when I didn't  mean to. 
2.  [ avoided letting myself get upset when I thought about i t  or  was reminded of it. 
3 .  I tried to remove it from memory. 
4. [ had trouble falling asleep or staying asleep, because of pictures or thoughts 
about it that carne into my mind. 
S .  I had waves of  strong feelings about it. 
6 .  I had dreams about it. 
7. [ stayed away from reminders about it. 
8 .  I felt as i f  it hadn't happened o r  i t  wasn't real. 
9 .  I tried not to talk about it. 
1 0 .  Pictures about i t  popped into m y  mind. 
I I . Other things kept making me think about it. 
1 2 . I was aware that I still had a lot of feelings about it. but I didn't  deal with them. 
1 3 .  I tried not to th ink  about it. 
1 4 . Any reminder brou&ht back feelings about it. 
I S . My feelings about it wen kind of numb. 
APPENDIX E:  
CONSENT FORMlResearch Information Sheet 
Dissertation Title: Healing Touch in H IV Disease 
Principle Investigators: Nancy L. McCain, RN, DSN 
Jo L.  Wheeler Robins, RN, MS, ANP 
Faculty Advisor: Nancy L. McCain, RN, DSN 
Page 1 of 2 
Medical College of Virginia HospitalsNirginia Commonwealth University 
You are being invited to participate in a research study on the influences of healing touch 
in persons with HIV infection. If you decide to participate, you will be one of 30 people who will 
be involved in this study. The study is designed to examine the effects of healing touch on well-
being, selected immune-related hormones, and several blood tests of immune system function. 
Healing touch is a therapy based on the idea that the human body is made up of energy 
and that imbalances or blockages in the flow of that energy can impair health and well-being. 
Energy based therapies have been shown to increase wel l-being and they may also enhance 
immune system functioning. The healing touch session will  last 20-30 minutes and will involve a 
nurse experienced in healing touch lightly placing her hands on specific areas of the body that 
correspond with the theorized major energy centers of the body. Your participation also wil l  help 
us to understand the influence of well-being on the immune system in HIV disease, and we may 
be able to provide better health care in the future. The only known risks or discomfort involved in 
this research are the brief pain of a needle-stick when having blood drawn from an arm vein, and 
the very sl ight chance of local infection at the site of the needle stick. Sterile procedures will be 
used to minimize the risk of such infection. 
If you decide to participate in this study, you will be involved for at least 4 weeks. In a 
random manner similar to the toss of a coin, you will be assigned ( I )  to the healing touch group 
or (2) to a wait list group to begin the study 4 weeks later. The healing touch treatment wil l  
involve 30-minute healing touch sessions once a week for 4 weeks. 
Research data will be collected at the beginning and end of the treatment group. If you 
are assigned to wait for the intervention, you will also have data collected at the beginning and 
Page 2 of 2 
end of the wait list period. Data collection will require about 30 minutes of your time and wil l  
involve having lab work drawn and completing a set o f  four brief questionnaires. Additionally, 
you will be asked to collect saliva samples the morning of data collection. At the 4-week data 
collection time, you will be paid $50. You will not be paid or allowed to continue in the study if 
you miss two of the healing touch sessions or a data collection time. 
In the event of physical and/or mental injury resulting from your participation in this 
research project, Virginia Commonwealth University will not provide compensation. If injury 
occurs, medical treatment wil l  be available at the Medical College of Virginia Hospitals .  Fees for 
such treatment will be bil led to you or to appropriate third party insurance. 
Your participation is entirely voluntary, and you may decide not to participate or to 
withdraw from the study without fear of disruption of the usual care, attention, or commitment of 
any of your health care or social services providers. Your participation and the information 
obtained wi l l  be kept strictly confidential, and it will not be possible to identify any participant 
from the reports or publications that may result from this research. You may ask questions now or 
at any time you wish in the future by contacting Jo Wheeler at or Nancy McCain 
at  If you have any questions concerning your rights as a research subject, you 
may contact the Committee on the Conduct of Human Research at for 
information or assistance. 
Your initials here indicate that you understand the nature and requirements for your 
participation in this research study, that you voluntarily agree to participate in the study as 
outlined here and verbally explained to you, and that you have received a copy of this form. 
YOUR INITIALS ONLY ______ _ 
Researcher's S ignature 
Date: 
APPENDIX F: 
Cytokine Data 
Participant 1 .0. I L-2 TNF-a IL-4 I L-6 
T reatment 
G roup 
02 Pre 24 979 1 . 3 1 6829 
Post 1 1 4 1  349 1 8 .4 252 1 3  
04 Pre 902 2 1 97 269 1 1 290 
Post 49 1 1 904 3 1 . 6 1 4746 
06 Pre 8 84 353 1 46765 
Post 1 853  4322 45573 
08 Pre 3 5 3  90 1 2 1 .4 27076 
Post 8 79 269 1 50 .7 4235 
1 2  Pre 78 1 99 1  30 275 
Post 7 223 2 . 9  6 7  
1 3  Pre 5 <0 .5 8 
Post 362 27 1 5  48 1 1 6 
1 6  Pre 1 007 54 1 7  3 . 3  3 7939 
Post 934 348 1 1 .2 3 78 1 8  
1 8  Pre 1 307 3 348 2 .6 37780 
Post 1 3 53 3030 7 .4 28974 
22 Pre 463 5 1 46 6 .6 25574 
Post 326 
24 Pre 22 1 4 1 3  1 . 8 655 
Post 1 3  9452 1 . 7 22652 
25 Pre 4 1 7  
Post 302 
27 Pre 59 1 523 5 . 9  1 5553 
Post 38  725 9640 
Control Group 
0 1  Pre 283 2908 5 . 1  3 8420 
Post 1 293 4760 8 . 2  35 764 
03 Pre 1 435  1 84 1  35427 
Post 43 1 25 1 6  1 5 . 7  5 1 0 
05 Pre 39  2676 <0 .25 3 1 22 1 
Post 79 1 260 5 . 1  3 1 34 
07 Pre 1 05 1 2 1 49 3 . 3  35 1 30 
Post 1 1. 1 5  
09 Pre 325 1 5 57  62. 1 1 4920 
Post 1 033  2404 1 95 3 1 23 
1 1  Pre 1 48 893 36825 
Post 1 5 8  1 307 1 5  39 1 47 
1 4  Pre 1 8  
Post 459 3060 58202 
1 5  Pre 893 2475 9 . 8  85565 
Post 449 2396 1 6 .4  59999 
1 7  Pre 1 7 1 4 2324 4 .8  52738 
Post 1 3  862 65 .7  47 1 
1 9  Pre 
Post 8 1 0 3983 3 . 3  48045 
2 1  Pre 1 67 2825 24 34548 
Post 444 3 369 1 7. 5  1 95 8 8  
2 8  Pre 
Post 44 1 832 1 9943 
